Journal of Geriatric Oncology - Volume 7/6 - Supplement 1

Editorial Board

Aims and Scope

SIOG 2016 - INVITED SPEAKER BIOGRAPHIES

Matti Aapro

Luca Arcaini

Patrizio Armeni

Lodovico Balducci

Gouri Shankar Bhattacharyya

Laura Biganzoli

Paolo Bossi

Etienne Brain

Bruno Castagneto

Kwok-Leung Cheung

Raul Cordoba

Andrea Costanzi

Nienke de Glas

Jean-Pierre Droz

Hassan Errihani

Marilène Filbet

Lucia Fratino

Tamas Fulop

Paolo Ghia

Marine Gilabert

Cesare Gridelli

Marije Hamaker

Arti Hurria

Ravindran Kanesvaran

Joseph Kattan

Karis Kin-Fong Cheng

Susan Knox

Ludmila Koch

Lalit Krishna

Ian Kunkler

Marco Ladetto

Alessandra Larocca

Trine Lembrecht Jørgensen

Stuart Lichtman

Laura Lozza

Andrea Luciani

Stefania Maggi

Michele Maio

Christos Markopoulos

Christophe Massard

Francesco Merli

Stefania Migliuolo

Olivier Mir

Nicolas Mottet

Loïc Mourey

Arash Naeim

Anita O’Donovan

Rebecca Olin

Nina Ommundsen

Roberto Orecchia

Cécile Ortholan

Demetris Papamichael

Heather Payne

Fausto Roila

Siri Rostoft

Patrick Roth

Florian Scotté

Ponnandai Somasundar

Pierre Soubeyran

Reinhard Stauder

Kazuo Tamura

William Tew

Clémence Thébaut

Janice Tsang

Giampaolo Ugolini

Willemien van de Water

Antonio Vigano

Ulrich Wedding

Tanya Wildes

Hans Wildiers

Annie Young

Gilbert Zulian

Contents

SIOG 2016 – Invited Speakers Abstract Submission

S01 MARGINAL ZONE AND LYMPHOPLASMACYTIC NHL: LESS COMMON, THOUGH STILL IMPORTANT, VARIANTS IN THE ELDERLY PATIENT Luca Arcaini Department of Molecular Medicine, University of Pavia, Department of Hematology Oncology, Pavia, Italy

S02 GENERATING EVIDENCE ABOUT EFFECTIVENESS AND VALUE Gouri Shankar Bhattacharyya In Charge Department of Medical Oncology, Medical Oncology, Kolkata, West, India

S03 ARE PATIENT REPORTED OUTCOMES PROGRAMMES ADAPTED TO THE GERIATRIC POPULATION? Paolo Bossi Head and Neck Medical Oncology, Medical Oncology, Milan, Italy

S04 INTRODUCTION: REPORT FROM THE ITALIAN NETWORK Bruno Castagneto GIOGer (Gruppo Italiano di Oncologia Geriatrica), Medical Department, Novi Ligure, Italia

S05 Romain Corre CHU Pontchaillou Pneumology, Rennes, France. The speaker abstract has not been received at the time of publication.

S06 GERIATRIC ONCOLOGY PRACTICE IN TROPICAL AREA: EXPERIENCE IN FRENCH GUIANA AND POSSIBLE RULES FOR IMPLEMENTATION IN LOW AND INTERMEDIATE INCOME COUNTRIES Jean-Pierre Droz Centre Léon-Bérard, Environment and Cancer Reasearch Unit, Lyon, France

S07 PROSTATE Jean-Pierre Droz Centre Léon-Bérard, Environment and Cancer Reasearch Unit, Lyon, France

S08 CANCER IN MOROCCAN ELDERLY: THE FIRST MULTICENTRIC TRANSVERSAL STUDY EXPLORING THE SOCIO-DEMOGRAPHIC AND ECONOMIC PROFILE OF MOROCCAN ELDERLY CANCER PATIENTS Hassan Errihani Mohamed V University, Medical oncology, Rabat, Morocco

S09 PALLIATIVE CARE FOR OLDER CANCER PATIENTS IN EUROPE Marilène Filbet CHU Lyon, Medecine palliative, Lyon, France

S10 ORGANIZATION MODELS OF THE CLINICAL ACTIVITY AT THE GIOGER CENTERS Lucia Fratino Oncology Unit, Aviano (PN), Italy

S11 GENITOURINARY TUMORS IN THE ELDERLY PATIENTS Lucia Fratino Oncology Unit, Aviano (PN), Italy

S12 IS IMMUNITY COMPROMISED IN THE ELDERLY AND DOES THIS IMPACT ON CANCER IMMUNOTHERAPY? Tamas Fulop Université de Sherbrooke, Medicine, Sherbrooke, QC, Canada

S13 CCL Paolo Ghia Università Vita-Salute San Raffaele, Division of Experimental Oncology, Milano, Italy

S14 Marine Gilabert. The speaker abstract has not been received at the time of publication.

S15 LUNG CANCER IN THE ELDERLY PATIENTS Cesare Gridelli "S.G. Moscati" Hospital, Medical Oncology, Avellino Italy

S16 GERIATRIC ASSESSMENT: NEXT BIG CHALLENGES Marije E Hamaker Diakonessenhuis, Geriatric Medicine, Utrecht, Netherlands

S17 Janice Tsang. The speaker abstract has not been received at the time of publication.

S18 PERSPECTIVES FROM NORTH AMERICA Holly Holmes University of Texas Health Science Center, Division of Geriatric and Palliative Medicine, Houston, USA

S19 NORTH AMERICA Arti Hurria Medical Oncology, Duarte, United States of America

S20 SIOG TASK FORCE FOR METASTATIC RCC IN THE ELDERLY 2016 Ravindran Kanesvaran National Cancer Centre Singapore, Medical Oncology, Singapore, Singapore

S21 Ravindran Kanesvaran National Cancer Centre Singapore, Medical Oncology, Singapore, Singapore. The speaker abstract has not been received at the time of publication.

S22 GERIATRIC ONCOLOGY PROJECTION IN THE MIDDLE-EAST: FINDINGS FROM LEBANON 2003–2023 Joseph Kattan Chair, Hematology-Oncology, Beirut, Lebanon

S23 DAILY LIVING WITH CANCER: THE PATIENT’S VOICE Susan Knox Europa Donna -The European Breast Cancer Coalition, Milan, Italy

S24 LATIN AMERICA Ludmila Koch Department of Medical Oncology, Sao Paulo, Brazil

S25 GERIATRIC ONCOLOGY: THE VIEW FROM LATIN AMERICA Ludmila Koch Department of Medical Oncology, Sao Paulo, Brazil

S26 PERSPECTIVES FROM ASIA—END-OF-LIFE ISSUES: RESPECTING THE PATIENT’S DIGNITY AROUND THE WORLD Lalit Krishna Deputy Program Director, Duke-NUS Practice Course Year 2 (Professionalism and Ethics), Assistant Professor, Duke-NUS Graduate Medical School Singapore, Assistant UG Curriculum Director (Clinical), Centre of Biomedical Ethics at NUS, Palliative Medicine, Singapore, Singapore

S27 ISSUES ON PAIN MANAGEMENT IN ELDERLY Lalit Krishna Deputy Program Director, Duke-NUS Practice Course Year 2 (Professionalism and Ethics), Assistant Professor, Duke-NUS Graduate Medical School Singapore, Assistant UG Curriculum Director (Clinical), Centre of Biomedical Ethics at NUS, Palliative Medicine, Singapore, Singapore

S28 MULTIPLE MYELOMA Alessandra Larocca A. O. Città della Salute e della Scienza di Torino, P.O. Molinette, Divisione Universitaria Ematologia 1, Torino, Italy

S29 STUDYING SUPPORTIVE CARE IN A NEW GERIATRIC ONCOLOGY PROGRAMME IN DENMARK Trine Lembrecht Jørgensen Odense University Hospital, Oncology, Odense, Denmark

S30 Demetris Papamichael. The speaker abstract has not been received at the time of publication.

S31 UPDATES IN RADIOTHERAPY Laura Lozza Fondazione IRCCS Istituto Nazionale Tumori, Radiation Oncology 1, Milano, Italy

S32 FUTURE STRATEGIES AND COLLABORATIONS Andrea Luciani Ospedale S. Paolo, Medical Oncology, Milan, Italy. The speaker abstract has not been received at the time of publication.

S33 CGA IN ADVANCED LUNG CANCER: WHAT HAVE WE LEARNED AND WHAT IS NEXT? NON-SMALL-CELL LUNG CANCER Andrea Luciani Ospedale S. Paolo, Medical Oncology, Milan, Italy

S34 UPDATES IN GERIATRICS Stefania Maggi CNR, Medicine, Aging Branch, Padua, Italy

S35 Michele Maio. The speaker abstract has not been received at the time of publication.

S36 FOLLICULAR NHL IN THE ELDERLY: ROLE OF GERIATRIC ASSESSMENT AND THERAPY Marco Ladetto. The speaker abstract has not been received at the time of publication.

S37 Christophe Massard DITEP, Villejuif, France. The speaker abstract has not been received at the time of publication.

S38 Christophe Massard DITEP, Villejuif, France. The speaker abstract has not been received at the time of publication.

S39 COMPREHENSIVE GERIATRIC ASSESSMENT AS STRATIFICATION TOOL IN ELDERLY PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES Francesco Merli Hematology Unit, Oncology and Advanced Technologies, Denmark

S40 QUALITY OF LIFE Stefania Migliuolo Europa Donna, Milan, Italy

S41 Olivier Mir. The speaker abstract has not been received at the time of publication.

S42 Loïc Mourey. The speaker abstract has not been received at the time of publication.

S43 WEARABLE AND HOME SENSORS Arash Naeim David Geffen School of Medicine, Department of Medicine, Los Angeles, CA, USA

S44 THE IMPACT OF RADIATION THERAPY ON THE QUALITY OF LIFE OF OLDER PATIENTS Anita O’Donovan Trinity College Dublin, Discipline of Radiation Therapy, School of Medicine, Dublin, Ireland

S45 PREHABILITATION BEFORE SURGERY Nina Ommundsen Oslo University Hospital, Geriatric Department, Oslo, Norway

S46 STEREOTACTIC AND OTHER PROMISING ADVANCED RADIATION TECHNIQUES IN ELDERLY Cécile Ortholan Department of Radiation Oncology, CHPG, Monaco

S47 PROSTATE CANCER Heather Payne University College Hospital, London, Oncology, London, UK

S48 TREATMENT OF ELDERLY PATIENTS WITH AML Rebecca Olin University of California San Francisco, Department of Medicine, San Francisco, USA

S49 Raul Cordoba. The speaker abstract has not been received at the time of publication.

S50 MASCC GUIDELINES IN FATIGUE ADAPTED TO GERIATRIC ONCOLOGY Fausto Roila Medical Oncology Division, Department of Oncology, Terni, Italy

S51 COGNITIVE DYSFUNCTION: WHY DOES IT MATTER IN OLDER PATIENTS WITH CANCER? Siri Rostoft Oslo university Hospital, Department of Geriatric Medicine, Oslo, Norway

S52 ARE GLIOBLASTOMA WELL TREATED IN THE ELDERLY? Patrick Roth University Hospital Zurich, Department of Neurology, Oslo, Norway

S53 DO WE NEED GUIDELINES? Florian Scotté European Hospital Georges Pompidou, Paris, France

S54 Florian Scotté European Hospital Georges Pompidou, Paris, France. The speaker abstract has not been received at the time of publication.

S55 UPDATES IN SURGERY Ponnandai Somasundar Boston University, Surgery, Providence, Rhode Island, USA

S56 SPECIAL CONSIDERATIONS WITH REGARD TO COLORECTAL SURGERY IN THE ELDERLY Andrea Costanzi Desio Hospital – ASST Monza, General Surgery, Desio (MB), Italy

S57 Pierre Soubeyran Université de Bordeaux, Medical Oncology, Bordeaux, France. The speaker abstract has not been received at the time of publication.

S58 Pierre Soubeyran Université de Bordeaux, Medical Oncology, Bordeaux, France. The speaker abstract has not been received at the time of publication.

S59 Pierre Soubeyran Université de Bordeaux, Medical Oncology, Bordeaux, France. The speaker abstract has not been received at the time of publication.

S60 WHO IS FIT FOR HAEMATOLOGICAL STEM CELL TRANSPLANTATION? Reinhard Stauder Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria

S61 WHO IS FIT FOR HAEMATOLOGICAL STEM CELL TRANSPLANTATION? Reinhard Stauder Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria

S62 HEALTH ECONOMICS Clémence Thébaut Limoges University (Lecturer Senior)/Dauphine University (Associate researcher), Paris, France

S63 CANCER TREATMENT SYSTEM IN JAPAN AND THE BEGINNING OF PRACTICE IN GERIATRIC ONCOLOGY Kazuo Tamura General Medical Research Center, General Medical Research Center, Fukuoka City, Japan

S68 GYNAECOLOGICAL CANCERS WilliamTew Memorial Sloan Kettering Cancer Center, Department of Medicine, Gynecologic Medical Oncology Service, New York, USA

S69 Janice Tsang. The speaker abstract has not been received at the time of publication.

S70 MINIMIZING PERIOPERATIVE ADVERSE EVENTS IN THE ELDERLY Giampaolo Ugolini University of Bologna, Department of Surgical and Medical Sciences, Bologna, Italy

S71 Willemien van de Water Surgery, Leiderdorp/ Leiden, Netherlands. The speaker abstract has not been received at the time of publication.

S72 IMPROVING NUTRITION STATUS SOONER RATHER THAN LATER Antonio Vigano McGill University Health Centre, Oncology, Montreal, Canada

S73 ARE TOOLS THE RIGHT WAY TO ASSESS QUALITY OF LIFE IN ELDERLY? Ulrich Wedding Jena University Hospital, Palliative Care, Jena, Germany

S74 MULTIPLE MYELOMA IN THE ELDERLY Tanya Wildes Barnes-Jewish Hospital, Division of Oncology, St. Louis, USA

S75 TELEHEALTH – RECENT EXPERIENCES IN ONCOLOGY Annie Young University of Warwick, Warwick Medical School, Coventry, UK

SIOG 2016 – Abstract Submission – Oral Presentations

O01 RELEVANCE OF GERIATRIC ASSESSMENT IN OLDER PATIENTS WITH COLORECTAL CANCER L. Decoster1,*, L. Vanacker1, C. Kenis2, H. Prenen2, E. Van Cutsem2, J. Van Der Auwera1, E. van Eetvelde1, K. Van Puyvelde3, J. Flamaing2, K. Milisen4, J. P. Lobelle5, J. De Grève1, H. Wildiers2 1UZ Brussel, Jette, 2UZ Leuven, Leuven, 3ASZ Aalst, Aalst, 4KU Leuven, Leuven, 5Consultant in Statistics, Beernem, Belgium

O02 NATIONAL PATTERNS OF CARE AND OUTCOMES OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS IN PATIENTS OVER 70 Z. D. Horne1,*, J. A. Vargo1, G. K. Balasubramani2, D. A. Clump1, R. L. Ferris3, D. E. Heron1, S. Beriwal1 1Department of Radiation Oncology, University of Pittsburgh Cancer Institute, 2Department of Epidemiology, University of Pittsburgh, 3Department of Head and Neck Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, USA

O03 GERIATRIC ASSESSMENT AND OUTCOMES WITH CARBOPLATIN AND WEEKLY LOW-DOSE PACLITAXEL IN ELDERLY WOMEN WITH OVARIAN, PRIMARY PERITONEAL OR FALLOPIAN TUBE CANCER: A GYNECOLOGIC ONCOLOGY GROUP STUDY (GOG273) W. Tew1,*, H. Huang2, V. Von Gruenigen3, A. Hurria4, T. Herzog5, L. Landrum6, R. Salani7, S. Lele8, M. Pearl9, A. Alvarez Secord10, J. Fiorica11, T. Rizack12, W. E. Richards13, G. Fleming14 1Dept of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, NY, 2GOG Statistics and Data Center, Buffalo, NY, 3Summa Akron City Hospital, Akron, OH, 4City of Hope, Duarte, CA, 5University of Cincinnati Cancer Institute, Cincinnati, OH, 6University of Oklahoma, OK, 7The Ohio State University Wexner Medical Center, OH, 8Roswell Park Cancer Institute, Buffalo, NY, 9Stony Brook University Hospital, Stony Brook, NY, 10Duke Cancer Center, NC, 11Indiana University, Bloomington, 12Women and Infants Hospital Rhode Island, RI, 13Candler Hospital, GA, 14University of Chicago, Chicago, IL, USA

O04 TAXANE-BASED ADJUVANT TREATMENT IN ELDERLY WOMEN WITH BREAST CANCER. A POOLED ANALYSIS OF 5 RANDOMIZED TRIALS FROM THE HELLENIC ONCOLOGY RESEARCH GROUP A. Karampeazis1,*, S. Kallianteri1, L. Vamvakas1, N. Kentepozidis1, P. Katsaounis1, N. Vardakis1, K. Kalbakis1, V. Georgoulias1 1Hellenic Oncology Research Group (HORG), Athens, Greece

O05 TRANSCRIPTION FACTORS AND CHECKPOINT INHIBITOR EXPRESSION WITH AGE: NEW MARKERS OF IMMUNOSENESCENCE? L. Dang1, K. Willard-Gallo2, S. Garaud2, H. Duvillier1, J.-N. Lodewyckx2, C. Solinas2, P. De Silva2, C. Gu-Trantien2, C. Sibille 3, D. Bron1,* 1Hematology, 2Molecular Immunology Unit, 3Antatomo-pathology, Institut Jules Bordet, Brussels, Belgium

O06 OFATUMUMAB AS FRONT-LINE TREATMENT FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA THAT ARE ELDERLY AND HAVE SEVERE CO-MORBIDITIES AND/OR OTHER MALIGNANCIES C. Vitale1, M. Ciccone1, C. Hinojosa1, M. J. Keating1, N. Pemmaraju1, W. G. Wierda1, G. Borthakur1, J. A. Burger1, A. Ferrajoli1,* 1Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, USA

O07 WHAT EVIDENCE DO WE HAVE FOR TREATING RELAPSED/ REFRACTORY AML IN PATIENTS 70 AND OLDER? A SYSTEMATIC REVIEW OF THE LITERATURE M. Extermann1,2,*, M. Sehovic1, T. Rejlic2, J. Kim3, J. Lancet2,4, B. Djulbegovic2,4 1Senior Adult Oncology Program, Moffitt Cancer Center, 2University of South Florida, 3Biostatistics Core, 4Hematology Program, Moffitt Cancer Center, Tampa, USA

O08 EARLY CASE MANAGEMENT IN THE OLDER FRENCH HEMATOLOGICAL MALIGNANCIES PATIENT RECEIVING CHEMOTHERAPY, PRELEMINARY RESULTS J. B. Fargeas1,*, Nicolas Signol, Marie-Agnès Picat, Diane Tilmant-Tatischeff, Julie Abraham, Marie-Pierre Gourin, Arnaud Jaccard, Dominique Bordessoule 1CHU, Limoges, France

O09 DEPRESSION IS ASSOCIATED WITH SLEEP DISTURBANCE IN OLDER ADULTS WITH CANCER K. P. Loh1,*, J. Zittel2, S. Kadambi2, C. Pandya1, A. Magnuson1, M. Flannery3, K. M. Mustian4, W. Dale5, S. G. Mohile1 1Hematology/Oncology, 2Medicine, 3Cancer Control, 4Surgery, University of Rochester/Strong Memorial Hospital, Rochester, 5Geriatrics & Palliative Medicine, University of Chicago Medicine, Chicago, USA

O10 A PHASE II RCT OF THREE EXERCISE DELIVERY METHODS IN OLDER MEN WITH PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY S. Alibhai1,*, D. Santa Mina2, P. Ritvo3, C. Sabiston4, M. Krahn4, G. Tomlinson4, P. Warde2, A. Matthew2, S. Durbano2, M. O’Neill2, R. Segal5, N. Culos-Reed6 1Medicine, 2University Health Network, 3Cancer Care Ontario, 4University of Toronto, Toronto, 5The Ottawa Hospital Cancer Centre, Ottawa, 6University of Calgary, Calgary, Canada

O11 PREVALENCE AND FACTORS ASSOCIATED WITH HIGH LEVEL OF DISTRESS AMONG OLDER CANCER PATIENTS UNDERGOING SURGERY A. Shahrokni1,*, L. Elmquist2, B. Korc-Grodzicki3 and MSKCC Cancer & Aging Research Program 1Medicine/Geriatrics and Oncology, 2Social Work, 3Medicine/ Geriatrics, Memorial Sloan Kettering Cancer Center, NYC, United States

O12 CHOOSING TO TRUST: CANCER TREATMENT DECISION MAKING FROM THE PERSPECTIVE OF OLDER ADULTS WITH COLORECTAL CANCER F. J. Strohschein1,2,3,*, H. Bergman4, R. S. Schreiber5, C. G. Loiselle2,3 1Department of Geriatrics, 2Segal Cancer Centre, Jewish General Hospital, 3Ingram School of Nursing, 4Department of Family Medicine, McGill University, Montreal, 5School of Nursing, University of Victoria, Victoria, Canada

O13 LONG TERM OUTCOME IN ELDERLY SURGICAL CANCER PATIENTS S. Stokmans1,*, E. Rotteveel1, H. van der Wal - Huisman1, G. de Bock2, A. Absalom3, B. van Leeuwen1 and PICNIC study group 1Surgical Oncology, 2Epidemiology, 3Anesthesiology, University Medical Center Groningen, Groningen, Netherlands

O14 INCLUSION OF ELDERLY PATIENTS IN ONCOLOGY CLINICAL TRIALS O. Le Saux1,*, C. Falandry2, H. K. Gan3, B. You4, G. Freyer5, J. Péron5 1Geriatric oncology, 2Centre Hospitalier Lyon Sud, Pierre-Bénite, France, 3Medical oncology, Austin Health, Heidelberg, Australia, 4Medical oncology, 5Institut de Cancérologie des Hospices Civils de Lyon, Pierre-Bénite, France

O15 LARGE OUTCOME DISPARITIES BY OLDER AGE AND 21GENE RECURRENCE SCORE (RS) RESULT IN HORMONE RECEPTOR POSITIVE (HR+) BREAST CANCER (BC) S. Shak1,*, V. I. Petkov2, D. P. Miller1, N. Howlader2, L. Penberthy2 1Genomic Health, Redwood City, 2National Cancer Institute, Bethesda, United States

O16 PRIMARY ENDPOINTS TO ASSESS TREATMENT EFFICACY IN CLINICAL TRIALS CONDUCTED IN ELDERLY CANCER PATIENTS F. Etchepare1,*, C. Terret2, F. Bonnetain3, P. Soubeyran4, L. Mourey5, D. Heitz6, E. Brain7, A. Bellenguez8, C. Bellera9, S. Mathoulin-Pélissier10 1Inserm U1219 Research Centre, Epicene Team (Epidemiology of Cancer and Environmental Exposure), Clinical Research and Clinical Epidemiology Unit, French National Cancer Institute (INCa) Integrated Cancer Research Site (SIRIC), Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, 2Department of Medical Oncology, Centre Léon Bérard, Regional Comprehensive Cancer Centre, Claude-Bernard Lyon-1/ Université de Lyon, Lyon, 3Unité de Méthodologie et qualité de vie en oncologie, EA3181, CHU Besançon, Besançon, 4French National Cancer Institute (INCa), Integrated Cancer Research Site (SIRIC), Department of Medical Oncology, INSERM U1218, Institut Bergonié, Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, 5Service d’Oncologie Médicale, Institut Claudius Regaud, IUCT-O, Toulouse, 6Service de Geriatrie, Hopitaux Universitaires de Strasbourg, Strasbourg, 7Service d’Oncologie Médicale, Hôpital René Huguenin/ Institut Curie, Saint-Cloud, 8Inserm U1219 Research Centre, Epicene Team (Epidemiology of Cancer and Environmental Exposure), Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Comprehensive Cancer Center, 9Inserm U1219 Research Centre, Epicene Team (Epidemiology of Cancer and Environmental Exposure), Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Comprehensive Cancer Centre, 10Inserm U1219 Research Center, Epicene Team (Epidemiology of Cancer and Environmental Exposure), Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Comprehensive Cancer Centre/Université de Bordeaux, Bordeaux, France

O17 FRAILTY AND SYSTEMIC INFLAMMATION-BASED GLASGOW PROGNOSTIC SCORE M. Harneshaug1,*, L. Kirkhus1, J. Šaltyte-Benth1,2,3, B. H. Grønberg4,5, S. Bergh1, J. E. Whist6, S. Rostoft7, M. S. Jordhøy3,8 1Research Centre for Old Age Psychiatry, Innlandet Hospital TRUST, Hamar, 2HØKH, Research Center, Akershus University Hospital, 3Institute of Clinical Medicine, Faculty of Medicine,, University of Oslo, Oslo, 4The Cancer Clininc, St. Olavs Hospital, Trondheim University hospital, 5Department of Cancer Research and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, 6Department of Medical Biochemistry, Innlandet Hospital TRUST, Lillehammer, 7Department of Geriatric Medicine, Faculty of Medicine, University of 0slo, Oslo, 8The Cancer Unit, Innlandet Hospital TRUST, Hamar, Norway

O18 A CLINICAL SCORE TO PREDICT THE EARLY DEATH AT 100 DAYS AFTER A COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) IN ELDERLY METASTATIC CANCERS, ANALYSIS FROM A PROSPECTIVE COHORT STUDY WITH 1048 PATIENTS R. Boulahssass1,*, S. gonfrier1, M. Sanchez1, V. Mari2, C. Rambaud1, J. M. Ferrero2, D. Saja2, J. M. Turpin1, A. Gary1, E. Francois2, O. Guerin2 1Chu de Nice,UCOG Paca Est, 2Centre antoine Lacassagne, Nice, France

O19 AN OBSERVATIONAL STUDY OF THE INTERVENTIONS PROVIDED BY A MULTIDISCIPLINARY TEAM PROVIDING COMPREHENSIVE GERIATRIC ASSESSMENT TO OLDER ADULTS WITH UPPER GASTRO-INTESTINAL CANCERS R. Morris1, A. Sims1,*, A. Smith1 1Health Care for Older People, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

O20 A FEASIBILITY TRIAL OF GERIATRIC ASSESSMENT AND INTEGRATED CARE PLAN FOR OLDER CANCER PATIENTS M. Puts1,*, S. Sattar1, K. McWatters1, K. Lee1, M. Kulik1, M. E. Macdonald1, S. Brennenstuhl1, R. Jang2, E. Amir2, M. Krzyzanowska2, A. Joshua2,3, J. Monette4, D. Wan-Chow-Wah5, S. Alibhai6,7 1Lawrence S.Bloomberg Faculty of Nursing, University of Toronto, 2Medical Oncology, University Health Network, Toronto, Canada, 3Medical Oncology, Kinghorn Cancer Centre, Sydney, Australia, 4Division of Geriatric Medicine, Jewish General Hospital, 5Division of Geriatric Medicine, McGill University Health Centre, Montreal, 6Medicine, University Health Network, 7Medicine, University of Toronto, Toronto, Canada

SIOG 2016 – Abstract Submission – Poster Presentations

P001 RETROSPECTIVE STUDY EVALUATING THE EFFICACY AND SAFETY OF FULVESTRANT AS FIRST OR SECOND LINE TREATMENT OF METASTATIC BREAST CANCER PATIENTS OVER 70 YEARS OF AGE A. I. Jagiello-Gruszfeld1,*, I. Lemanska1, E. Szombara1, E. Brewczynska1, A. Gorniak1, A. Majstrak-Hulewska1, Z. Nowecki1 1Breast Cancer and Reconstructive Surgery Dept, Memorial Cancer Center and Institute, Warsaw, Poland

P002 PRACTICE MANAGEMENT FOR ELDERLY PATIENTS WITH BREAST CANCER FROM IMPLICATIONS OF A SURVEY BY THE JAPAN CLINICAL ONCOLOGY GROUP A. Shimomura1,*, M. Sawaki2, K. Tamura1, T. Mizutani3, Y. Taki2, F. Nagashima4, H. Iwata2 1Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 2Breast Oncology, Aichi Cancer Center Hospital, Nagoya, 3JJCOG Data Center/Operations Office, Center for Research Administration and Support, National Cancer Center, 4Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

P003 SERUM METABOLOMIC PROFILES FOR DISCRIMINATING EARLY FROM METASTATIC DISEASE IN ELDERLY PATIENTS WITH COLORECTAL CANCER E. Mori1,2, A. R. A. Mislang2,*, A. Vignoli3, S. Di Donato2, C. Biagioni2, S. Vitale1,2, C. Hart2, D. Becheri4, F. Del Monte2, C. Luchinat3, A. Di Leo2, G. Mottino4, L. Biganzoli2, L. Tenori5 1University of Siena, Siena, 2Medical Oncology Department, Nuovo Ospedale-Santo Stefano Instituto Toscano Tumori, Prato, 3Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, 4Geriatric Medicine Department, Nuovo Ospedale-Santo Stefano Instituto Toscano Tumori, Prato, 5Consorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine (CIRMMP), Sesto Fiorentino, Italy

P004 OUTCOMES OF HYPO FRACTIONATED RADICAL RADIOTHERAPY IN PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC) OVER THE AGE OF 80 A. Cree1,*, J. Haston1, A. McPartlin1, L. Joseph2, H. Sheikh1, M. Harris1, J. Coote1, R. Stout1, N. Bayman1, L. Lee1, C. Chan1, C. Favre Finn1, L. Pemberton1 1Clinical Oncology, The Christie NHS Foundation trust, Manchester, 2Clinical Oncology, Leeds Cancer Institute, Leeds, United Kingdom

P005 THE BENEFIT AND TOLERABILITY OF ADJUVANT CHEMOTHERAPY IN ELDERLY STAGE III COLON CANCER PATIENTS: A 3 YEAR RETROSPECTIVE AUDIT A. Srivastava1,*, M. B. Jameson1, H.-S. Lin1, D. Turner1 1Medical Oncology, Waikato Hospital, Hamilton, New Zealand

P007 DIFFERING BIOLOGY OF BREAST CANCER ACCORDING TO AGE B. M. Syed1, A. R. Green2, I. O. Ellis2, K. L. Cheung3,* 1Medical Research Centre, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan, 2Pathology, 3Breast Surgery, University of Nottingham, Nottingham, United Kingdom

P008 COMORBIDITY AND CORRELATION WITH ADJUVANT CHEMOTHERAPY OUTCOMES IN PATIENTS WITH COLORECTAL CANCER C. Lund1,*, D. Nielsen2, C. Dehlendorff3, F. Rønholt1, J. S. Johansen2, K. K. Vistisen2 1Department of Medicine, 2Department of Oncology, Herlev Hospital, 3Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

P009 OUTCOME AND AGE DEPENDENT DIFFERENCES IN CHOICE OF ADJUVANT CHEMOTHERAPY IN PATIENTS WITH PRIMARY COLORECTAL CANCER (THE ACCORE STUDY) C. Lund1,*, D. Nielsen2, C. Dehlendorff3, F. Rønholt1, A. B. Christiansen2, J. S. Johansen2, K. K. Vistisen2 1Department of Medicine, 2Department of Oncology, Copenhagen University Hospital, Herlev, 3Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark

P010 A PROSPECTIVE NON-INTERVENTIONAL STUDY ON THE USE OF BEVACIZUMAB AND CONVENTIONAL CHEMOTHERAPY FOR FIRST LINE ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): TREATMENT DURATION AND TOXICITY C. Kenis1,*, L. Decoster2, H. Wildiers1, G. Houbiers3, B. Naessens4, M. De Man5, G. Lambrecht6, E. Monsaert7, V. Moons8, P. Vergauwe9, H. Prenen1, L. Opstaele10, E. Van De Walle11, E. Van Cutsem1 1UZ Leuven, Leuven, 2UZ Brussels, Brussels, 3CHC Clinique St Joseph, Liege, 4AZ Nikolaas, St.Niklaas, 5OLV Aalst, Gent, 6AZ Damiaan, Oostende, 7AZ Maria Middelares, Gent, 8Imeldaziekenhuis, Bonheide, 9AZ Groeninge, Kortrijk, 10Innosens, 11Roche NV/SA, Brussels, Belgium

P011 RETROSPECTIVE STUDY OF FRENCH PHYSICIANS’ PRACTICES IN CAPECITABINE PRESCRIPTION FOR OLDER PATIENTS WITH METASTATIC FIRST LINE BREAST CANCER (CAPAGE STUDY) D. Chauvière1,*, J. Viotti2, Y. Chateau2, P. Follana3, J.-M. Ferrero3, O. Guerin4, E. Francois5, V. Mari3, R. Boulahssass4 1Clinical research, 2Biostatistic Unit, 3Medical oncology, Centre Antoine Lacassagne, 4UCOG Paca-est, CHU Nice, 5UCOG Paca-est, Centre Antoine Lacassagne, Nice, France

P012 ASTER 70S OR OPTIMAL ADJUVANT TREATMENT FOR WOMEN OVER 70 WITH LUMINAL BREAST CANCER: A GERICO/UNICANCER PHASE III TRIAL F. Coussy1, O. Mir2, E. Bourbouloux3, S. Kirscher4, O. Rigal5, J.-M. Ferrero6, D. Allouache7, P. Cottu8, G. Romieu9, E. Blot10, A.-M. Savoye11, X. Durando12, F. Duhoux13, L. Venat-Bouvet14, E. Malaurie15, C. Lefeuvre16, J.-L. Canon17, M. Lacroix-Triki18, F. Rollot19, F. Hermitte20, C. Orsini21, C. Dubot22, F. Bonnetain23, E. G. C. Brain1,* 1Medical Oncology, Institut Curie/Hôpital René Huguenin, SaintCloud, 2Medical Oncology, Institut Gustave Roussy, Villejuif, 3Medical Oncology, Institut de Cancérologie de l’Ouest ICO, Nantes, 4Instituts de cancérologie d’Avignon, Avignon, 5Centre Henri Becquerel, Rouen, 6Centre Antoine-Lacassagne, Nice, 7Centre François Baclesse, Caen, 8Institut Curie - Site Paris, Paris, 9Institut régional du Cancer Montpellier/Val d’Aurelle Centre Val d’Aurelle - Paul Lamarque, Montpellier, 10Centre hospitalier de Vannes, Vannes, 11Institut Jean Godinot, Reims, 12Centre Jean Perrin, Clermont Ferrand, France, 13Cliniques universitaires Saint-Luc, Louvain, Belgium, 14CHU de Limoges, Limoges, 15CHI de Créteil, Créteil, 16Centre Eugène Marquis, Rennes, 17Grand Hopital de Charleroi (GHdC), Charleroi, 18Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, 19Hôpital René Huguenin/Institut Curie, SaintCloud, 20HalioDx, Marseilles, 21UNICANCER, Paris, 22Institut Curie, Saint-Cloud, 23CHU Besançon, Besançon, France

P013 FUNCTIONAL AND COGNITIVE IMPAIRMENT, SOCIAL ENVIRONMENT, FRAILTY AND ADVERSE HEALTH OUTCOMES IN OLDER PATIENTS WITH HEAD AND NECK CANCER, A SYSTEMATIC REVIEW F. J. A. Van Deudekom1,*, A. S. Schimberg2, M. H. Kallenberg1,3, M. Slingerland4, L.-A. van der Velden2,5, S. P. Mooijaart1,6 1Gerontology and Geriatrics, 2Department of Otorhinolaryngology and Head and Neck Surgery, 3Department of Nephrology, 4Department of Medical Oncology, Leiden University Medical Centre, Leiden, 5Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, 6Institute for Evidence-based Medicine in Old Age, Leiden, Netherlands

P014 DESCRIPTIVE EPIDEMIOLOGICAL STUDY OF GERIATRIC CANCER SEEN IN TATA MEMORIAL HOSPITAL, MUMBAI G. Balasubramaniam1,*, S. L. Saoba1, R. A. Badwe2, A. K. Decruz3 1Medical records, Biostatistics & Epidemiology, Tata Memorial Hospital, 2Director, Tata Memorial Centre, 3Director, Tata Memorial Hospital, Mumbai, India

P015 COMBINATION CHEMOTHERAPY WITH DOCETAXEL AND CARBOPLATIN FOR ELDERLY PATIENTS WITH ENDOMETRIAL CANCER H. Yoshida1,*, Y. Imai1, K. Fujiwara1 1Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

P016 LONG SURVIVAL OF A METASTATIC BREAST CANCER SERIES OF ELDERLY PATIENTS IN A COMPREHENSIVE CANCER CENTER I. Morilla1,*, A. Stradella1, V. Navarro2, A. Rodriguez1, M. Gil1, M. Antonio1, S. Recalde1, S. Pernas1 1Clinical Oncology, 2Clinical Trial Unit, Instituto Catalan de Oncologia, Hospitalet de Llobregat, Spain

P017 IL-6 SECRETION REDUCTION IN ELDERLY PATIENTS UNDERGOING ELECTIVE COLORECTAL LAPAROSCOPIC SURGERY UNDER ERAS. RESULTS FROM A RANDOMIZED CLINICAL TRIAL A. Costanzi1,*, G. Mari1, J. Crippa1, A. Miranda1, A. Rosato1, V. Berardi1, D. Maggioni1 1General Surgery, Desio Hospital, Desio, Italy

P018 OCTOGENARIANS WITH INOPERABLE MALIGNANT PLEURAL MESOTHELIOMA: OUTCOME OF CARBOPLATIN AND PEMETREXED CHEMOTHERAPY. A SIX YEARS CONSECUTIVE COHORT J. B. Sørensen1,*, J. N. Jakobsen1 1Dept. Oncology, Finsen Centre/National University Hospital Copenhagen, Copenhagen, Denmark

P020 MULTIDISCIPLINARY DECISION-MAKING IN LUNG CANCER PATIENTS: AN AGED BASED COMPARISON K. J. Schulkes1,*, M. E. Hamaker2, J. J. Lammers3, M. M. van Rens1, M. Geerts1, L. J. van Elden1 1Pulmonology, 2Geriatric Medicine, Diakonessenhuis Utrecht, 3Pulmonology, UMC Utrecht, Utrecht, Netherlands

P021 POSTOPERATIVE COMPLICATIONS AND MORTALITY IN INDIVIDUALS AGED 70 AND OLDER UNDERGOING SURGERY FOR COLORECTAL CANCER K. Fagard1,*, J. Casaer2, A. Wolthuis3, J. Flamaing4, K. Milisen5, J.-P. Lobelle6, H. Wildiers7, C. Kenis8 1Department of Geriatric Medicine, University Hospitals Leuven, 2Faculty of Medicine, KU Leuven, 3Department of Abdominal Surgery, University Hospitals Leuven, 4Department of Geriatric Medicine, Department of Clinical and Experimental Medicine, University Hospitals Leuven, KU Leuven, 5Department of Geriatric Medicine, Department of Public Health and Primary Care, University Hospitals Leuven, Academic Centre for Nursing and Midwifery, KU Leuven, 6Consultant in Statistics, University Hospitals Leuven, 7Department of General Medical Oncology, Department of Oncology, University Hospitals Leuven, KU Leuven, 8Department of General Medical Oncology, Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium

P022 EFFICACY AND SAFETY OF ANTIANGIOGENIC THERAPIES IN ELDERLY PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A RETROSPECTIVE MULTICENTER STUDY L. Pierard1,*, F. Schaff-Wendling1, A. Thiéry2, C. Korenbaum1, J. Gantzer1, D. Heitz1, B. Duclos1, C. Borel3, J.-E. Kurtz1, P. Barthélémy1 1Medical Oncology Unit, University Hospital Strasbourg, 2Epidemiology and Biostatistics Department, 3Medical Oncology Unit, Centre Paul Strauss, Strasbourg, France

P023 TOLERANCE AND EFFICACY OF FOLFIRINOX IN ELDERLY PATIENTS WITH PANCREACTIC OR COLORECTAL CANCER. A MONOCENTRIC RETROSPECTIVE STUDY ON 52 PATIENTS J. F. Guion-Dussere1, A. Bertaut2, F. Ghiringhelli1, J. Vincent1, V. Quipourt3,4, S. Marilier3,4, L. Bengrine Lefevre1,4,* 1Medical oncology, 2statistic department, Centre Georges François Leclerc, 3geriatric department, CHU Champmaillot, 4UCOG Bourgogne, Dijon, France

P024 GERIATRIC ASSESSMENT AND FUNCTIONAL DECLINE IN OLDER PATIENTS WITH LUNG CANCER L. Decoster1,*, C. Kenis2, D. Schallier1, J. Vansteenkiste2, K. Nackaerts2, L. Vanacker1, N. Vandewalle1, J. Flamaing2, J. Lobelle3, K. Milisen4, J. De Grève1, H. Wildiers2 1UZ Brussel, Jette, 2UZ Leuven, Leuven, 3Consultant in statistics, Beernem, 4KU Leuven, Leuven, Belgium

P025 UTILITY OF GERIATRIC ASSESSMENT IN ELDERLY PATIENTS WITH LOCALLY ADVANCED LUNG CANCER TO BE TREATED WITH CONCURRENT CHEMORADIATION M. T. Antonio Rebollo1,*, J. Saldaña2, J. Linares2, M. D. Arnaiz2, J. C. Rufinelli2, J. Gonzalez-Barboteo2, V. Navarro3, A. Navarro4, F. Cardenal2, E. Nadal2 1Medical Oncology, Institut Català d’Oncologia. Hospital Duran i Reynals, 2Medical Oncology, 3Clinical Research Unit, 4Radiotherapy Oncology, Institut Català d’Oncologia-Hospital Duran i Reynals, Barcelona, Spain

P026 CLUSTERING ANALYSIS OF OESTROGEN RECEPTOR POSITIVE EARLY OPERABLE PRIMARY BREAST CANCER IN OLDER WOMEN – A STUDY BASED ON CORE NEEDLE BIOPSY M. A. Albanghali1, G. P. Figueredo2, M. A. Aleskandarany 1, A. R. Green 1, E. A. Rakha 1, C. Nolan 1, M. Díez-Rodríguez1, J. M. Garibaldi 2, I. O. Ellis1, K. L. Cheung1,* 1School of Medicine, 2School of Computer Science, University of Nottingham, Nottingham, United Kingdom

P027 FINAL RESULTS OF GERICO 10 GETUG P03 TRIAL EVALUATING FEASIBILITY OF DOCETAXEL IN VULNERABLE OR FRAIL ELDERLY (75+) PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER M. Loic1,*, I. Latorzeff2, N. Houede3, J. Meunier4, F. Priou5, G.-M. Gwenaëlle6, E. Carola7, C. Orsini8, T. Filleron9 1Medical Oncology, Institut Claudius Regaud - IUCT-Oncopole, 2Radiotherapy, Clinique Pasteur, Toulouse, 3Medical Oncology, CHU, Nîmes, 4Medical Oncology, CHR, Orléans, 5Medical Oncology, CH Vendée, La Roche sur Yon, 6Medical Oncology, Institut Paoli Calmette, Marseille, 7Medical Oncology, CH, Senlis, 8R&D Unicancer, Paris, 9Methodologist, Institut Claudius Regaud - IUCT-Oncopole, Toulouse, France

P028 UNRESECTABLE AND METASTATIC PANCREATIC ADENOCARCINOMA IN THE ELDERLY: A 10-YEAR SINGLE-CENTER EXPERIENCE M. Langlois1,*, A. Beaudoin1, F. Lemay1 1University of Sherbrooke, Sherbrooke, Canada

P029 THE IMPACT OF AN OSTOMY ON OLDER COLORECTAL CANCER PATIENTS: A CROSS-SECTIONAL SURVEY N. Verweij1, M. Hamaker2,*, D. Zimmerman3, T. van Loon3, F. van den Bos4, A. Pronk5, I. Borel Rinkes6, A. Schiphorst5 1Surgery/Geriatrics, 2Geriatrics, Diakonessenhuis, Utrecht, 3Surgery, Tweesteden Ziekenhuis, Tilburg, 4Internal medicine, Haga ziekenhuis, Den Haag, 5Surgery, Diakonessenhuis, 6Surgery, UMC, Utrecht, Netherlands

P030 HCC ASSOCIATED WITH HIGHEST INPATIENT POST-OPERATIVE MORTALITY AMONGST GI CANCERS: ELDERLY AGE HIGHEST PREDICTIVE RISK FACTOR P. Somasundar1,*, G. Cholankeril2, A. Ahmad1, M. Hu3 1Surgery, Roger Williams Medical Center, Providence, USA, 2Medicine, Roger Williams Medical Center, Providence, Bahamas, 3Statistics, Brown University, Providence, USA

P031 RETROSPECTIVE CORELATION OF BIOPSY WITH PSA SCREENING VALUES OF GERIATRIC INDIVIDUALS IN A TERTIARY CARE TEACHING HOSPITAL IN INDIA R. Unnikrishnan1,*, S. Senan1 1Geriatrics, Amrita Institute of Medical Sciences, Kochi, Kerala, India

P033 ARE OLDER PATIENTS PROPERLY REPRESENTED IN CLINICAL TRIALS? ANALYSIS OF THE SCREENING FAILURES REASONS IN ELDERLY NON-SMALL CELL LUNG CANCER PATIENTS (NSCLC) STAGE IV ASSESSED FOR BEVACIZUMAB THERAPY (GIDO1201 TRIAL) R. Gironés1,*, F. Aparisi2, M. de Julián3, A. Sánchez-Hernández3, A. Blasco4, S. Blasco5, O. Juan6, on behalf of GIDO and GIDO: Grup d´investigació i divulgació en oncologia 1Medical Oncology Unit, Hospital Lluis Alcanyis, Xàtiva, 2Medical Oncology Unit, Hospital Virgen de Los Lirios, Alcoi, 3Medical Oncology Unit, Hospital Provincial, Castellón, 4Medical Oncology Unit, Hospital General, Valencia, 5Medical Oncology Unit, Hospital de Sagunto, Sagunto, 6Medical Oncology Unit, Hospital Universitari i Politècnic, Valencia, Spain

P034 SHORT-TERM CHANGES IN MOOD AS MEASURED BY COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) SCORES FOLLOWING TREATMENT OF PRIMARY BREAST CANCER IN OLDER WOMEN R. M. Parks1,*, P. Howard2, K. Cox2, K.-L. Cheung1 1School of Medicine, 2School of Health Sciences, University of Nottingham, Nottingham, United Kingdom

P035 ANDROGEN DEPRIVATION THERAPY AND THE RISK OF PARKINSONISM IN OLDER MEN WITH PROSTATE CANCER S. M. Alibhai1,2,*, R. Sutradhar3, J. Rangrej3, C. Marras4, N. Fleshner5, J. W. Young1 1Medicine, University of Toronto, 2Medicine, University Health Network, 3Institute for Clinical Evaluative Sciences, 4Neurology, 5Surgery, University Health Network, Toronto, Canada

P036 CLINICAL AND TREATMENT FACTORS ASSOCIATED WITH SURVIVAL AMONG WOMEN 70 YEARS AND OLDER WITH EPITHELIAL OVARIAN CANCER S. E. Robertson1,*, B. R. Khulpateea 1, Y. Xiong1, K. O’Hara2, M. Extermann1, H. S. Chon1 1Moffitt Cancer Center, Tampa, USA, 2Hospital General Universitario Gregorio Maranon, Madrid, Spain

P037 SAFETY AND EFFICACY OF LOWER DOSE WEEKLY TOPOTECAN IN ELDERLY PATIENTS WITH PLATINUM RESISTANT OVARIAN AND PERITONEAL CANCER V. Michalaki1,*, T. Panoskaltsis2, G. Frangulidis3, N. Dafnios3, C. Papadimitriou1 1Oncology, 2Gynecology, 3Surgery, Areteion Hospital University of Athens, Athens, Greece

P038 DO WE KNOWWHAT OLDER WOMEN WITH BREAST CANCER WANT? DECISION MAKING PREFERENCES FOR TYPE OF TREATMENT, FOLLOW UP AND PERCEPTIONS OF COSMETIC OUTCOMES Y. K. Jain1, D. Tognali2, R. Audisio1,* 1General Surgery, St Helens and Knowlsey Teaching Hospitals NHS Trust, Prescot, United Kingdom, 2General Surgery, University of Brescia, Brescia, Italy

P039 ASSOCIATION OF PRE-CHEMOTHERAPY PERIPHERAL BLOOD BIOMARKERS OF AGING (IL-6, CRP AND D-DIMER) WITH CHEMOTHERAPY TOXICITY AND RELATIVE DOSE INTENSITY (RDI) IN WOMEN WITH BREAST CANCER Y. Yuan1,*, N. Vora2, C. Sun1, D. Li1, J. Mortimer1, G. Somlo1, J. Waisman1, J. Chao1, V. Katheria1, T. Synold1, V. Tran1, S. Mi1, A. Levi1, S. Yost1, A. Arsenyan1, L. Zavala1, J. Choi1, A. Hurria1 1City of Hope National Cancer Center, Duarte, 2Long Beach Memorial Hospital, Long Beach, USA

P040 DIFFUSE LARGE B CELL LYMPHOMA: AN OVERVIEW OF THE DISEASE WITH SPECIAL FOCUS ON CIRS SCALE AND EMERGENCY VISITS IN THE ELDERLY POPULATION C. Plaza Meneses1, T. Arquero Portero1, B. Zheng1, M. Yuste Platero1, T. Villaescusa de la Rosa1, J. L. Lopez Lorenzo1, M. A. Pérez Sáenz1, E. Prieto Pareja1, F. Lobo Samper1, P. Llamas Sillero1, R. Cordóba Mascuñano1,* 1Hematology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

P041 COMPREHENSIVE GERIATRIC ASSESSMENT MAY BE USEFUL ITEM AS PREDICTIVE INDEX OF TREATMENT COMPLETION FOR ELDERLY PATIENTS WITH LYMPHOMA M. Shibata1,* 1Internal medicine, Kawanishi, Japan

P042 SEGA (SHORT EMERGENCY GERIATRIC ASSESSMENT) FRAILTY SCORE IN ELDERLY PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES N. Carnel1,*, J. Poisson, T. Guerekobaya, P. Genet, A. Andreoli, A. Al Jijakli, B. Poujol, L. Mesbah, L. Sutton, D. Chaoui 1Haematology unit, Centre hospitalier Victor Dupouy, Argenteuil, France

P043 A NEW FRAILTY SCORING IN “CLINICALLY FIT” OLDER PATIENTS WITH MALIGNANT HEMOPATHIES ADMITTED TO RECEIVE CHEMOTHERAPY S. Dubruille1,2, C. Kenis3, Y. Libert2, M. Delforge4, J. Alexis Ruiz 1, M. Roos5, A. Collard5, N. Meuleman1, M. Maerevoet1, D. Razavi2, H. Wildiers3, D. Bron1,* 1Department of Hematology, 2Clinic of Psycho-Oncology, Institut Jules Bordet, Brussels, 3Department of Oncology, 4Department of Hematology, University Hospitals Leuven, Leuven, 5Onco-geriatry Unit, Institut Jules Bordet, Brussels, Belgium

P044 EFFECT OF ADEQUATE HYPOMETHYLATING AGENT (HMA) THERAPY ON ADVERSE PROGNOSTIC FACTORS IN VERY ELDERLY PATIENTS (75 YRS) WITH MYELODYSPLASTIC SYNDROME (MDS) V. Lohiya1,*, G. Sherwood1, U. Borate1 1Hematology/Oncology, University of Alabama at Birmingham, Birmingham, USA

P045 FALLS IN OLDER CANCER PATIENTS UNDERGOING SURGERY: PREVALENCE AND ASSOCIATION WITH GERIATRIC SYNDROMES AND LEVELS OF DISABILITY ASSESSED IN PREOPERATIVE EVALUATION S. Fahimnia1, A. Shahrokni2,*, B. Korc-Grodzicki1 1Medicine/Geriatrics, 2Medicine/Geriatrics and Oncology, Memorial Sloan Kettering Cancer Center, NYC, USA

P048 FRACTURES IN OLDER CANCER PATIENTS, A CALL FOR ACTION B. Edwards1,*, H. Holmes2, P. Khalil1, M. Sun1, H. Valladarez1, J. Song3, X. Zhang1 1Internal Medicine, University of Texas, MD Anderson Cancer Center, 2Medical School, University of Texas, 3Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, USA

P049 NEUROCOGNITIVE PROFILE IN OLDER CANCER PATIENTS IN A GERIATRIC CLINIC B. Edwards1,*, H. Holmes2, P. Khalil1, M. Sun1, H. Valladarez1, J. Song3 1Internal Medicine, University of Texas, MD Anderson Cancer Center, 2Medical School, University of Texas, 3Biostatistics, University of Texas, MD Anderson Cancer Center, Houston, USA

P050 RESCUE GCS-F USE AS A MARKER OF SAFETY OF ANTICANCER TREATMENTS IN GERIATRIC PATIENTS IN REGIONAL AND RURAL SOUTH AUSTRALIA D. M. Poprawski1,*, M. Buxton2 1Cancer Services, Country Health South Australia, Elizabeth Vale SA 5112, 2Pharmacy, Country Health South Australia, Mt Gambier, Australia

P051 SARCOPENIA IS ASSOCIATED WITH AN UNPLANNED READMISSION AND WORSE SURVIVAL FOLLOWING ESOPHAGECTOMY D. Makiura1,2,*, R. Ono1, J. Inoue2, Y. Sakai3, Y. Miura1 1Kobe University Graduate School of Health Sciences, 2Division of Rehabilitation, Kobe University Hospital, 3Kobe University Graduate School of Medicine, Division of Rehabilitation Medicine, Kobe City, Japan

P052 CLINICAL IMPLICATION OF BODY MASS INDEX, SKELETAL MASS INDEX AND RELATED BLOOD MARKERS IN THE ELDERLY PATIENTS WITH SOLID TUMORS D. S. Sun1,*, S. L. Lee2, Y. M. Ku2, H. S. Won2, J. Y. Choi2, Y. H. Ko3 1Medical Oncology, Uijeongbu St. Mary’s Hospital, Uijeongbu City, 2Uijongbu St. Mary’s Hospital, Uijongbu city, 3Uijongbu St. Mary’s Hospital, Uijongbu cityl, Republic Of Korea

P053 THE BEHAVIORAL AND PSYCHOLOGICAL OUTCOMES OF CANCER SURVIVORS: RESULTS FROM THE IRISH LONGITUDINAL STUDY ON AGEING E. Ryan1, A. O’Donovan1,*, R. A. Kenny2 1Trinity College Dublin, 2The Irish Longitudional Study of Aging, Dublin, Ireland

P054 ASSESSMENT OF RENAL FUNCTION AMONG PATIENTS WITH BONE METASTASES FROM SOLID TUMORS G. S. Bhattacharyya1,*, H. Malhotra2, K. Govindbabu3, R. Singh4, A. Vora5, T. P. Sahoo6 1Medical Oncology, Fortis Hospital, Anandapur, EM Bye Pass Road, Kolkata, (WB), India, Kolkata, 2Medical Oncology, SMS Medical College & Hospital, Jaipur, 3Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, 4Medical Oncology, HCG-SMH Cancer Centre, 5Medical Oncology, MaxHospital, New Delhi, 6Medical Oncology, Jawaharlal Nehru Cancer Hospital & Research Centre, Bhopal, India

P055 PROPHYLACTIC USE OF FILGRASTIM TO MANAGE CHEMOTHERAPY-INDUCED NEUTROPENIA IN ELDERLY PATIENTS I. Krakrowski1, J.-L. Mouysset2, D. Burlacu3, K. Benabed4, M. Hacini5, A. El Weshi6, P. Janoray7, R. Diab8,*, D. Badinand9, M. Gardner10, N. Sakek11, E. Fabre12, N. Jovenin13, S. Corbinais14, K. Laribi15 1Institut Bergonié, Bordeaux, 2Clinique Rambot Provençale, Aix en Provence, 3Centre Hospitalier Henri Mondor, Aurillac, 4Hopital Côte de Nacre, Caen, 5CH de Chambery, Chambery, 6CH du Cotentin site de Cherbourg, Cherbourg Octeville, 7Institut de Cancérologie de Bourgogne, Dijon, 8CHI Emile Durkheim Site Epinal, Epinal, 9CHU La Timone, Marseille, 10Hôpital Clinique Claude Bernard-Centre Privé de Radiothérapie, Metz, 11Hôpital Nord Franche Comté Site Le Mittan, Montbeliard, 12Hôpital Européen Georges Pompidou (HEGP), Assistance Publique Hôpitaux de Paris (AP-HP), Paris, 13Clinique François 1er, Saint Dizier, 14CH St Malo, St Malo, 15CH Le Mans, Le Mans, France

P056 CHEMOTHERAPY AND HEALTH CARE UTILISATION NEAR THE END OF LIFE IN PATIENTS WITH LUNG CANCER K. J. Schulkes1,*, I. C. van Walree2, L. J. van Elden1, D. ten Bokkel Huinink3, M. E. Hamaker2 1Pulmonology, 2Geriatric Medicine, 3Internal Medicine, Diakonessenhuis Utrecht, Utrecht, Netherlands

P057 MANAGEMENT OF ELDERLY PATIENTS SUFFERING FROM CANCER: ASSESSMENT OF PERCEIVED BURDEN AND QUALITY OF LIFE OF PRINCIPAL CARER V. Quipourt1,2, L. Bengrine Lefevre2,3,*, S. Dabakuyo4, S. Marilier1,2, P. Manckoundia1, P. Arveux4, V. Germain5 1Geriatrician, CHU DIJON, 2UCOG Bourgogne, 3Medical oncology, 4statistician, Centre Georges François Leclerc, 5General practitioner, liberal practitioner, DIJON, France

P058 NEUTROPHIL ENGRAFTMENT AND GRAFT-VERSUSHOST DISEASE IN ELDERLY PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: IMPORTANCE OF BODY COMPOSITION ASSESSMENT AND GERIATRIC L. Koch1,*, R. J. Garcia Filho1, N. Hamerschlak1, A. D. A. e Castro1, C. C. da Silva1, A. Tachibana1, C. Prado2, A. Z. Pereira1 1Department of Medical Oncology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, 2Department of Nutrition, Food and Exercise Sciences, University of Alberta, Edmonton, Canada

P059 EFFICACY AND SAFETY OF ROLAPITANT IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS AGED <65 VERSUS 65 YEARS RECEIVING MULTIPLE CYCLES OF EMETOGENIC CHEMOTHERAPY M. Aapro1,*, D. Powers2, S. Arora2 1IMO Clinique de Genolier, Genolier, Switzerland, 2Tesaro, Inc., Waltham, MA, USA

100

P060 POTENTIALLY INAPPROPRIATE MEDICATION USE IN ELDERLY BREAST AND COLORECTAL CANCER PATIENTS M. Karuturi1,*, S. S. Giordano2, H. Holmes3, M. Johnson4, X. Lei2 1Breast Medical Oncology, 2Health Services Research, MD Anderson Cancer Center, 3Geriatric and Palliative Medicine, University of Texas Health Science Center at Houston, 4University of Houston College of Pharmacy, Houston, USA

101

P061 POTENTIAL DRUG INTERACTIONS IN OLDER PATIENTS WITH CANCER: THE ELCAPA COHORT SURVEY (ELCAPA-15) G. Beinse1, D. Reitter2, L. Segaux3, M. Carvahlo-Verlinde2, C. Tournigand4, T. Cudennec5, E. Paillaud1,*, F. Canouï-Poitrine3, P. Caillet1 on behalf of ELCAPA Study Group 1Department of Internal and Geriatric Medicine, 2Department of Pharmacy, 3Department of Public Health and Clinical Research Unit (URC-Mondor), 4Department of Medical Oncology, APHP - Hôpital Henri MONDOR, 5Department of Geriatrics, AP-HP, Hôpital Ambroise Paré, Créteil, France

101

P063 APPLICATION OF ADEPT (A PROCESS FOR DECISIONMAKING AFTER PILOT AND FEASIBILITY TRIALS) TO A PILOT GERIATRIC ONCOLOGY PROGRAMME IN RADIATIONTHERAPY A. O’Donovan1,*, C. Gillham2, C. Cunningham3, P. Thirion2, M. Cunningham2, N. ElBeltagi2, M. Leech1 1Radiation Therapy, Trinity College Dublin, 2Saint Luke’s Radiation Oncology Network, 3Saint James’s Hospital, Dublin, Ireland

102

P064 RADICAL RADIOTHERAPY IN PATIENTS AGED OVER 80: A SINGLE UK CENTRE EXPERIENCE A. Cree1,*, A. Lewis2, R. Cowan1 1Clinical Oncology, The Christie NHS Foundation trust, 2Medical Oncology, The Christie NHS Foundation, Manchester, United Kingdom

103

P065 HIDDEN PREOPERATIVE GERIATRICS SYNDROMES IN PATIENTS WITH AMERICAN SOCIETY OF ANESTHESIOLOGISTS CLASS III A. Shahrokni1,*, B. M. Vishnevsky2, B. Korc_Grodzicki3 1Medicine/Geriatrics and Oncology, Memorial Sloan Kettering Cancer Center, 2Medicine, Weill Cornell Medical College, 3Medicine/ Geriatrics, Memorial Sloan Kettering Cancer Center, NYC, USA

104

P066 THE USE OF DOSE-DENSE WEEKLY PACLITAXEL (WP) CHEMOTHERAPY IN GERIATRIC PATIENTS WITH GYNAECOLOGICAL CANCERS A. Pericao1,*, F. El-Khouly1, M. McCormack1, R. Kristeleit1, J. Ledermann1, R. Miller1 1University College London Hospital, London, United Kingdom

105

P067 THE EFFECT OF AGE ON PATIENT REPORTED OUTCOMES FOLLOWING RADICAL PROSTATE RADIOTHERAPY A. Nuhoglu Savas1,*, L. Sellers2, A. Al-Abdullah2, R. Ramiswami3, R. Davda2, A. V. Mitra2, H. Payne2 1Department of Medical Physics and Biomedical Engineering, University College London, 2Department of Oncology, University College London Hospital, 3Department of Oncology, Charing Cross Hospital, London, United Kingdom

105

P068 HOWTO ADDRESS THE HETEROGENEITY IN THE DESIGN OF PHASE II CLINICAL TRIALS IN GERIATRIC ONCOLOGY? B. Cabarrou1,*, E. Leconte2, L. Mourey3, P. Sfumato4, L. Balardy5, C. Bellera6,7, J.-P. Delord3, J.-M. Boher4, T. Filleron1 1Department of Biostatistics, Insititut Claudius Regaud - IUCT-O, 2TSE-R, Université Toulouse 1 Capitole, 3Department of Oncology, Insititut Claudius Regaud - IUCT-O, Toulouse, 4Department of Biostatistics, Institut Paoli Calmettes, Marseille, 5Department of Oncology, CHU, Toulouse, 6Elderly and Cancer Platform - French League Against Cancer, 7Department of Biostatistics, Institut Bergonié - Comprehensive Cancer Center, Bordeaux, France

106

P070 HOME-BASED PREHABILITATION AND REHABILITATION TO OPTIMIZE PHYSICAL FITNESS AND TREATMENT OUTCOMES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER : A SYSTEMATIC REVIEW E. J. Driessen1,*, M. E. Peeters2, B. C. Bongers3, H. A. Maas4, G. P. Bootsma5, N. L. van Meeteren6, M. L. Janssen-Heijnen1 1Epidemiology, VieCuri Medical Centre, Venlo, 2Physical Therapy, Knooppunt Centre for Health, Baarlo, 3Epidemiology, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, 4Geriatric Medicine, Elisabeth-TweeSteden Hospital, Tilburg, 5Pulmonology, Zuyderland Medical Centre, Heerlen, 6Topsector Life Sciences and Health, Health Holland, The Hague, Netherlands

107

P071 ECHOCARDIOGRAPHIC EVALUATION OF CARDIOTOXIC DRUGS IN GERIATRIC CANCER PATIENTS: BEYOND EJECTION FRACTION G. Sokol1,*, L. Loftus2, J. Ayub3, L. Cantilena1 1Clinical Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, 2Breast Program, Moffitt Cancer Center, Tampa, 3Florida Cancer Specialists, Hudson, USA

108

P072 PROSPECTIVE COHORT STUDY FROM THE EORTC (1221-ETF) ON THE OCCURRENCE OF CANCER EVENTS IN BELGIAN NURSING HOME RESIDENTS (NHR) H. Wildiers1,*, M. Elseviers2, M. Mauer3, J. Dewolf4, E. Bastiaens5, S. Hatse6, M. Hamaker7, F. Buntinx8, J. Delepeleire9, G. Uytterschaut10, K. Tryfonidis5, M. Janssen-Hejinen11 on behalf of EORTC Elderly Task Force 1General Medical Oncology, University Hospitals Leuven, Leuven, 2Centre for Research and Innovation in Care (CRIC), Faculty of Medicine, Antwerp, 3EORTC- Headquarters, Brussels, 4Drug Research Unit Ghent, Ghent University Hospital, Ghent, 5EORTC headquarters, Brussels, 6Laboratory of Experimental Oncology (LEO), KULeuven, Leuven, Belgium, 7Department of Geriatric Medicine, Diakonessenhuis, Utrecht, Netherlands, 8Department of General Practice, Universities of Leuven and Maastricht, 9Departement of General Practice KU Leuven and University Psychiatric Hospital, KULeuven, leuven, 10Armonea, Mechelen, Belgium, 11Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, Netherlands

108

P073 CLINICAL BENEFIT RATE AND PARTICIPATION OF PATIENTS WITH ADVANCED CANCER ON PHASE I CLINICAL TRIALS: A COMPARATIVE ANALYSIS OF SENIOR ADULTS AGED 65 YEARS AND ABOVE VERSUS MIDDLE AGE AND AYA PATIENTS I. M. Subbiah1,*, C. Tang1, A. Rao1, V. Subbiah1, R. Kurzrock2, D. Karp1, D. S. Hong1 1University OF Texas MD Anderson Cancer Center, Houston, 2University of California San Diego Moores Cancer Center, San Diego, USA

109

P074 EPIDURAL BASED ANESTHESIA FOR FRAIL ELDERLY PATIENTS IN BREAST CANCER SURGERY: METHOD OF CHOICE? J. Wallage1,2,*, H. Harbers2, I. den Hoed3, H. Maas4, R. van Ieperen2, G. J. Noordergraaf2 1Anesthesiology, Pain and Palliative Care, RadboudUMC, Nijmegen, 2Anesthesiology, Pain Management & Resuscitation, 3Department of Surgery, 4Department of Geriatric Medicine, Elisabeth Tweesteden Hospital, Tilburg, Netherlands

109

P075 MAY THERAPEUTIC DRUG MONITORING OF 5FU DECREASE TOXICITY IN ELDERLY? A RETROSPECTIVE STUDY L. Bengrine Lefevre1,2,*, V. Quipourt2,3, J. Vincent1, A. Cueff4,5, L. Marceau5, M. Deveaux5, S. Marilier2,3, F. Ghiringhelli1,6, A. Schmitt5,7 1Medical oncology, Centre Georges François Leclerc, 2UCOG Bourgogne, 3Geriatric department, CHU Champmaillot, 4statistic department, Centre Georges François Leclerc, 5EA 4184, Burgundy University, 6UMR 866, INSERM, 7Pharmacy department, Centre Georges François Leclerc, Dijon, France

110

P076 OLDER PATIENTS RECEIVING CHEMOTHERAPY: CHARACTERISING THE POPULATION F. Holt1, M. Denholm1,*, J. Hampton2, P. Corrie3 1Department of Oncology and Department of Medicine for the Elderly, 2Department of Medicine for the Elderly, 3Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

111

P077 SALVAGE SURGERY OF NON-SMALL CELL LUNG CANCER IN ELDERLY PATIENTS WITH PREVIOUS WEDGE RESECTION OR LOBECTOMY A. Tortoriello1, A. J. Blair1, C. E. B. Iniguez1, M. T. Jaklitsch1,* 1Brigham & Women’s Hospital, Boston, USA

111

P078 EPITOP-01: ELDERLY CANCER PATIENTS, SAFETY AND QUALITY OF LIFE UNDER IMMUNOTHERAPIES: A PHASE IV TRIAL R. Sabatier1, C. Zemmour2, S. Durand3, F. Goldwasser4, F. Rousseau1,* and Société Francophone d’Oncocogériatrie 1Medical Oncology, 2Biostatistics, 3Pharmacy, Institut Paoli Calmettes, Marseille, 4Medical Oncology, Hopital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France

112

P079 PREDICTORS OF POSTOPERATIVE COMPLICATIONS IN ELDERLY PATIENTS AGED 80 YEARS OR OLDER UNDERGOING CANCER SURGERY T. Karnakis1,*, L. A. Gil Junior2, A. L. Kanaji1, M. D. C. Sitta3, M. C. B. Pereira3, W. Jacob Filho3 1Geriatrics, 2ICESP, 3Geriatrics, University of São Paulo, São Paulo, Brazil

113

P080 TREATMENT OF CHEMO-RESISTANT CANCERS IN THE ELDERLY POPULATION: ROLE OF MOLECULAR TUMOR PROFILING M. Ghosn1, T. Ibrahim1, A. Ahmadie1, A. Saroufim1, C. Hanna1, F. el Karak1, F. Farhat1, J. Kattan1,* 1Hematology Oncology, Faculty of Medicine Saint Joseph University, Beirut, Lebanon

114

P081 USING BIG DATA IN ONCOLOGY TO PROSPECTIVELY IMPACT CLINICAL PATIENT CARE: A PROOF OF CONCEPT STUDY V. Dougoud-Chauvin1,*, J. J. Lee1, E. S. Santos2, V. L. Williams1, N. M. Battisti1, K. M. Ghia1, M. Sehovic1, W. Kramer2, C. Croft1, J. Kim1, L. Balducci1, J. A. Kish1, M. Extermann1 1H. Lee Moffitt Cancer Center and Research Institute, Tampa, 2Eugene M. & Christine E. Lynn Cancer Institute, Boca Raton, USA

114

P082 GERIATRIC ONCOLOGY NEEDS ASSESSMENT OF GENITOURINARY CANCER SITE GROUP: THE GERIATRIC ONCOLOGY DEMONSTRATION PROJECT A. Loucks1,*, R. Jin1, P. Savage2, G. Rodin3, M. Puts4, S. Alibhai5 1Nursing Geriatric Oncology, 2Director of Professional Practice, 3Director of Supportive Care, Princess Margaret Cancer Centre, 4Nursing Geriatric Oncology, University of Toronto, 5Geriatric Oncologist, Princess Margaret Cancer Centre, Toronto, Canada

115

P083 PRE-OPERATIVE ASSESSMENT AND POST-OPERATIVE OUTCOMES OF ELDERLY WOMEN WITH GYNECOLOGIC CANCERS, PRIMARY ANALYSIS OF NRG CC-002 A. Ahmed1,*, W. Deng2, W. Tew3, D. Bender4, R. Littell5, A. DeNittis6, M. Edelson7, M. Morgan8, J. Carlson9, L. Small10, A. Fleury11, S. Modesitt12, A. Olawaiye13, A. Evans14, G. Fleming15 and NRG Oncology 1OBGYN, Gynecologic Oncology, Rush University Medical Center, Chicago, 2GOG, Buffalo, 3Memorial Sloan Kettering, new york, 4University of Iowa, Iowa City, 5Kaiser Permanente, San Francisco, 6Mainline, Wynnewood, 7Abington Jefferson Health, Abington, 8University of Pennsylvania, Philidelphia, 9Cancer Center Research for the Ozarks, Springfield, 10Maine Medical Partners, Scarborough, 11Women’s Caner Center of Nevada, Las Vegas, 12University of Virginia, Charlottesville, 13University of Pittsburgh, Pittsburgh, 14Marshfield Clinic, Marshfield, 15University of Chicago, Chicago, USA

116

P084 PREDICTION OF FUNCTIONAL DECLINE AND 1 YEAR SURVIVAL IN ELDERLY CANCER PATIENTS USING COMPREHENSIVE GERIATRIC ASSESSMENT A. L. Kanaji1,*, W. Jacob Filho1, T. Karnakis1, L. A. Gil Jr1, T. C. A. Rotta1 1Geriatrics, ICESP, São Paulo, Brazil

116

P085 CLINICAL RELEVANCE OF ONCOLOGICAL DIAGNOSIS IN FRAIL ELDERLY PATIENTS A. Luciani1,*, C. Careri2, S. Caldiera2, M. Violati2, D. Ferrari2, P. Foa1 1Medical Oncology, 2Ospedale S. Paolo, Milano, Italy

117

P086 EVALUATION OF PATIENT PERCEPTIONS OF TEAM BASED CARE IN A GERIATRIC ONCOLOGY MULTIDISCIPLINARY INTERPROFESSIONAL CLINIC A. E. Chapman1,*, K. Swartz2, L. Collins2, S. Sicks3 1Department of Medical Oncology, 2Family and Community Medicine, 3Jefferson Center for Interprofessional Education, Thomas Jefferson University, Philadelphia, USA

118

P087 A CHALLENGE IN ONCOGERIATRICS: IS ROCKWOOD FRAILTY INDEX AN ACCURATE TOOL TO PREDICT CLINICAL OUTCOMES? A. Mazzeo1,*, F. Monacelli2, P. Odetti2, C. Russo2, S. Sambuceti2, M. Canepa2, T. Granello2, A. Nencioni2, R. Murialdo3, A. Ballestrero3, S. Scabini4, E. Romairone4, F. De Cian5, F. Boccardo6 1Department of Internal Medicine and Medical Specialties Section of Geriatric Medicine, 2Department of Internal Medicine and Medical Specialties Section of Geriatric Medicine, 3Department of Internal Medicine and Medical Specialties Section of Internal Oncological Medicine, 4Oncological surgery and implantable system surgery, 5Academic Surgery Department of Surgical Science and Integrated Diagnostics, 6Department of Internal Medicine and Medical Specialties Section of Clinical Oncology, I.R.C.C.S. San Martino-IST Genova, Genova, Italy

118

P088 THE ONCOLOGICAL MULTIDIMENSIONAL PROGNOSTIC INDEX (ONCO-MPI) HELPS PREDICTING BENEFITS OF TREATMENT FOR PATIENTS WITH ADVANCED COLORECTAL CANCER: A PROSPECTIVE SINGLE CENTER STUDY A. Brunello1,*, S. Lonardi1, F. Bergamo1, R. Intini1, L. V. Rumanò1, S. Ahcene-Djaballah1, P. Fiduccia 2, A. Lettiero1, G. Tierno1, A. Pilotto 3, V. Zagonel1 1Medical Oncology 1 Unit, 2Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto, Padova, 3Geriatric Care, Orthogeriatrics and Rehabilitation, Frailty Area, Galliera Hospital, Genova, Italy

119

P091 FUNCTIONAL DECLINE IN OLDER PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY: A MULTICENTER PROSPECTIVE STUDY C. Kenis1,*, L. Decoster2, J. Bastin3, H. Bode3, K. Van Puyvelde4, J. De Grève2, G. Conings2, K. Fagard5, J. Flamaing6, K. Milisen7, J.-P. Lobelle8, H. Wildiers9 1General Medical Oncology and Geriatric Medicine, University Hospitals Leuven, Leuven, 2Medical Oncology, Oncologisch centrum, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, 3General Medical Oncology, University Hospitals Leuven, Leuven, 4Frailty in Aging (FRIA) Research Group & Gerontology Department, Vrije Universiteit Brussel, Brussels, 5Geriatric Medicine, University Hospitals Leuven, 6Geriatric Medicine & Clinical an Experimental Medicine, 7Geriatric Medicine & Public Health and Primary Care, Academic Centre for Nursing and Midwifery, University Hospitals Leuven & KU Leuven, Leuven, 8Consultant in Statistics, Beernem, 9General Medical Oncology & Oncology, University Hospitals Leuven & KU Leuven, Leuven, Belgium

119

P092 SCREENING FOR MULTIDIMENSIONAL HEALTH PROBLEMS IN OLDER PATIENTS WITH CANCER: EFFECT OF VARYING GOLD STANDARD DEFINITIONS ON THE DIAGNOSTIC PERFORMANCE OF THE G8 AND MODIFIED G8 SCREENING TOOLS C. M. Martinez-Tapia1,*, M. Laurent1,2, E. Paillaud1,2, J.-L. Lagrange3, M. Allain4, A. Chahwakilian5, P. Boudou-Rouquette6, S. Bastuji-Garin1,4,7, E. Audureau1,7 and the ELCAPA Study Group 1EA 7376 CEpiA (Clinical Epidemiology and Ageing Unit), Université Paris Est, 2Internal Medicine and Geriatric Department, 3Department of Medical Oncology, 4Clinical Research Unit, HenriMondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, 5Oncogeriatrics, Geriatric Department, Broca Hospital, Hôpitaux Universitaires Paris Centre, Assistance Publique-Hôpitaux de Paris, 6Department of Medical Oncology, Cochin hospital, Hôpitaux Universitaires Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris, 7Public Health Department, Henri-Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France

120

P093 A RANDOMIZED CONTROLLED TRIAL OF GERIATRIC ASSESSMENT GUIDED MULTIDISCIPLINARY INTERVENTIONS: THE FIRST YEAR EXPERIENCE D. Li1,*, C. Kelly1, M. Trent1, M. Fakih1, M. Koczywas1, M. Cristea1, S. Pal1, V. Chung1, J. Mortimer1, Y. Yuan1, P. Burhenn1, V. Katheria1, D. Rivera1, G. Varatkar1, K. Yu1, S. Hite1, D. Mitani1, B. Ferrell1, A. Hurria1 1City of Hope, Duarte, USA

121

P095 EVALUATION OF THE G8, VES-13 AND FRIED FRAILTY CRITERIA AS SCREENING TOOLS FOR MULTIDIMENSIONAL HEALTH PROBLEMS IN PATIENTS ENROLLED IN A PHASE II TRIAL OF GERIATRIC ASSESSMENT AND MANAGEMENT FOR OLDER ADULTS WITH CANCER D. W. Yokom1,*, S. Alibhai2,3, M. Puts4 1Division of Medical Oncology, 2Department of Medicine, University of Toronto, 3Department of Medicine, University Health Network, 4Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada

121

P096 EFFECTIVENESS OF THE FLEMISH VERSION OF TRIAGE RISK SCREENING TOOL IN DETECTING FRAILTY IN ELDERLY PATIENTS UNDERGOING EMERGENCY SURGERY: A PILOT STUDY D. Zattoni1,*, M. Cervellera1, P. Calogero2, C. Galetti2, A. Garutti2, M. L. Bacchi Reggiani3, V. Tonini1 1Emergency Surgery, 2Geriatrics, 3Cardiology, Policlinico S. OrsolaMalpighi, Bologna, Italy

122

P097 DESCRIPTIVE ANALYSIS OF THE ONCOGERIATRIC COHORT OF PICARDY (COPAGE): CORRELATION BETWEEN G8 AND THE BALDUCCI SCORE E. Carola1,*, R. Fournier2, G. Bonnet2, A. Chebah3, D. Assouan4, S. Hannat5, F. Woerth6, B. Chauffert4 and UCOG de Picardie 1Medical Oncology, GHPSO, Senlis, 2CHU, Amiens, 3oncologie médicale, GHPSO, Senlis, 4oncologie médicale, 5gériatrie, CHU, Amiens, 6Gériatrie, GHPSO, Senlis, France

123

P098 STUDY PROTOCOL: GERIATRIC SCREENING TOOLS AND THE OUTCOME OF TREATMENT IN ONCOGERIATRIC PATIENTS E. H. Van Den Hout1,*, F. J. van Deudekom2, G. J. de Klerk3, K. J. Kalisvaart4 1Intern Medicine, Spaarne Gasthuis, Haarlem, 2Geriatric Medicine, Medisch Centrum Slotervaart, Amsterdam, 3Intern Medicine, Oncology, 4Geriatric Medicine, Spaarne Gasthuis, Haarlem, Netherlands

123

P099 PERFORMANCE OF FOUR FRAILTY CLASSIFICATIONS IN OLDER PATIENTS WITH CANCER: PROSPECTIVE ELCAPA COHORT STUDY E. Ferrat1,*, E. Paillaud1, P. Caillet1, M. laurent1, C. Tournigand2, J.-L. Langrange3, J. P. Droz4, L. Balducci5, E. Audureau1, F. Canoui-Poitrine1, S. Bastuji-Garin1 on behalf of the ELCAPA Study Group 1CEPIA EA7376, 2Département oncologie médicale, APHP HenriMondor, 3Département de radiothérapie, APHP Henri-Mondor, Créteil, 4Claude-Bernard-Lyon-1 University and Department of Medical Oncology, Centre Léon-Bérard, Lyon, France, 5H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

124

P100 A PILOT STUDY OF AN ACCELERATOR EQUIPPED SMARTPHONE TO MONITOR OLDER ADULTS WITH CANCER RECEIVING CHEMOTHERAPY IN MEXICO E. Soto-Perez-De-Celis1,*, M. P. Rojo-Castillo1, Y. Chavarri-Guerra2, A. P. Navarrete-Reyes1, J. R. Waisman3, J. A. Avila-Funes1, Á. Aguayo2, A. Hurria4 1Department of Geriatrics, 2Department of Hemato-Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Department of Medical Oncology & Therapeutics Research, 4Cancer and Aging Research Program, City of Hope, Duarte, USA

125

P102 TRANS SECTORAL CARE OF GERIATRIC CANCER PATIENTS BASED ON COMPREHENSIVE GERIATRIC ASSESSMENT AND PATIENT-REPORTED QUALITY OF LIFE H. Schmidt1,*, S. Boese1, K. Lampe2, K. Jordan3, E. Fiedler4, U. Mueller-Werdan5, D. Vordermark2 1Institute of Health and Nursing Sciences, Martin Luther University Halle-Wittenberg, 2Department of Radiation Oncology, 3Department of Hematology and Oncology, 4Department of Dermatology, University Hospital Halle Saale, Halle (Saale), 5Protestant Geriatric Centre, Charite - Universitätsmedizin Berlin, Berlin, Germany

126

P103 EVALUATION OF TWO ONCO-GERIATRIC SCORE SYSTEMS FOR PREDICTION OF THERAPY-ASSOCIATED TOXICITY IN ELDERLY CANCER PATIENTS I. Ortland1,*, M. T. Mendel1, M. Kowar2, Y.-D. Ko3, A. H. Jacobs2, U. Jaehde1 1Institute of Pharmacy, Clinical Pharmacy, University of Bonn, 2Department of Geriatrics and Neurology, 3Department of Oncology and Hematology, Johanniter Hospital Bonn, Bonn, Germany

127

P104 FOUR MODELS OF FRAILTY IN COLORECTAL CANCER PATIENTS QUALIFIED FOR ELECTIVE SURGERY J. Kenig1,*, A. Papier1, P. Walega1, O. Urszula1, W. Nowak1 13rd Department of General Surgery, Jagiellonian University Medical College, Krakow, Poland

127

P105 IMPLEMENTATION OF THE G8 SCREENING TOOLS IN A PUBLIC HOSPITAL IN FRENCH GUIANA J.-L. Joachim1, E. Basset1, S. Briolant2, B. Cenciu1, P. Couppié1, J.-P. Droz3,4,* 1Medicine, 2Geriatrics, Cayenne Hospital, 3Oncoguyane Cancer Network, Cayenne, French Guiana, 4Environment and Cancer Research Unit, Centre Léon-Bérard, Lyon, France

128

P106 FUNCTIONAL DEPENDANCY IS PREDICTIVE FOR NUTRITIONAL STATUS IN ELDERY PATIENTS WITH HEMATOLOGIC MALIGNANCIES J. Hajder1,*, N. Stanisavljevic1, D. Marisavljevic1,2, O. Markovic1,3, R. Zivkovic1 1Hematology, KBC Bezanijska kosa, Belgrade, Serbia, 2Hematology, Medical faculty, 3Hematology, Medical faculty, Belgrade, Serbia

128

P107 COMPARING TRADITIONAL PERFORMANCE STATUS ASSESSMENT WITH MOBILE HEALTH ACTIVITY DATA AS A MEASURE OF FUNCTION J. Shen1,*, K. Vander Wall1, A. Petruse1, J. Trent1, R. Ramezani1, M. Sarrafzadeh1, A. Naeim1 1University of California, Los Angeles, Los Angeles, USA

129

P108 QUALITY OF LIFE AND EARLY MORTALITY IN OLDER CANCER PATIENTS J. T. D. O. L. Sales1,*, M. J. G. Mello1, L. C. S. Thuler1, A. Bergmann1, M. Rebelllo1, C. R. Ximenes1 1Oncology, IMIP, recife, Brazil

129

P109 THE USE A COMPREHENSIVE GERIATRIC ASSESSMENT TO SEARCH FOR FACTORS ASSOCIATED WITH HIGHER RISK OF SHORT-TERM OUTCOMES J. T. D. O. L. Sales1,*, M. J. G. Mello1, R. Travassos1, D. Sales1, Z. Cavalcanti1, M. Rebello1, R. Cavalcanti1, A. Bergman 2, L. C. S. Thuler1 1Oncology, IMIP, Recife, 2Oncology, INCA, Rio de Janeiro, Brazil

130

P110 VALUE OF GERIATRIC SCREENING AND ASSESSMENT IN PREDICTING POSTOPERATIVE COMPLICATIONS IN PATIENTS OLDER THAN 70 YEARS UNDERGOING SURGERY FOR COLORECTAL CANCER K. Fagard1,*, J. Casaer2, A. Wolthuis3, J. Flamaing4, K. Milisen5, J.-P. Lobelle6, H. Wildiers7, C. Kenis8 1Department of Geriatric Medicine, University Hospitals Leuven, 2Faculty of Medicine, KU Leuven, 3Department of Abdominal Surgery, University Hospitals Leuven, 4Department of Geriatric Medicine, Department of Clinical and Experimental Medicine, University Hospitals Leuven, KU Leuven, 5Department of Geriatric Medicine, Department of Public Health and Primary Care, University Hospitals Leuven, Academic Centre for Nursing and Midwifery KU Leuven, Leuven, 6Consultant in Statistics, University Hospitals Leuven, Beernem, 7Department of General Medical Oncology, Department of Oncology, University Hospitals Leuven, KU Leuven, 8Department of General Medical Oncology, Department of Geriatric Medicine, University Hospitals Leuven, Leuven, Belgium

131

P111 FRAILTY AND SURVIVAL IN OLD PATIENTS WITH CANCER; CLINICAL JUDGMENT AND SYSTEMATIC GERIATRIC ASSESSMENTS L. Kirkhus1,*, J. Šaltyte Benth 1,2,3, S. Rostoft4, B. H. Grønberg5,6, M. J. Hjermstad7,8, G. Selbæk1,9, T. Bruun Wyller3,4, M. Harneshaug1, M. S. Jordhøy3,10 1The Centre for Old Age Psychiatry Research, Innlandet Hospital Trust, Hamar, 2HØKH Research Centre, Akershus University Hospital, 3Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 4Department of Geriatric Medicine, Oslo University Hospital, Oslo, 5The Cancer Clinic, St. Olavs Hospital - Trondheim University Hospital, 6Department of Cancer Research and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, 7Regional Advisory Unit for Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, 8European Palliative Care Research Centre, Department of Cancer Research and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, 9Norwegian Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, 10The Cancer Unit, Innlandet Hospital Trust, Hamar, Norway

131

P112 A PROSPECTIVE NON-INTERVENTIONAL STUDY ON THE USE OF BEVACIZUMAB AND CONVENTIONAL CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC COLORECTAL (MCRC) PATIENTS: SCREENING AND GERIATRIC ASSESSMENT (GA) L. Decoster1,*, C. Kenis2, G. Houbiers3, B. Naessens4, M. De Man5, G. Lambrecht6, V. Moons7, E. Monsaert8, P. Vergauwe9, H. Prenen2, E. Van Cutsem2, E. Beutels10, D. Frijns11, H. Wildiers2 1UZ Brussels, Brussels, 2UZ Leuven, Leuven, 3Gastroenterology and Digestive Oncology, CHC Clinique St Joseph, Liege, 4AZ Nikolaas, St.Niklaas, 5OLV Aalst, Gent, 6AZ Damiaan, Oostende, 7Imeldaziekenhuis, Bonheide, 8AZ Maria Middelares, Gent, 9AZ Groeninge, Kortrijk, 10Innosens, 11Roche NV/SA, Brussels, Belgium

132

P113 CANCER SURVIVORSHIP AND AGING – IS IT SO DIFFERENT FOR ELDERLY AND YOUNG? M. Bernardo1,*, S. Ouakinin2, S. Eusébio3, L. Ribeiro1, O. Nunes1, J. Silva4 1Hemato-oncology, Hospital CUF infante santo, 2Psychiatry, 3Psychology /Psychiatry, Fac Medicine Univ Lisboa, 4Radiotherapy, Hospital CUF descobertas, Lisboa, Portugal

133

P114 EVALUATION OF THE IMPACT OF COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) IN OLDER PATIENTS WITH KIDNEY CANCER M. Sanchez1, R. Boulahssass2,*, S. Gonfrier1, D. Saja1, C. Rambaud1, J. M. Turpin1, F. Leborgne1, E. Clais1, E. Francois3, O. Guerin1 1UCOG, CHU, 2UCOG, 3UCOG, Centre Antoine Lacassagne, Nice, France

133

P115 SENIOR TORONTO ONCOLOGY PANEL – RESEARCH PARTICIPATION FOR OLDER ADULTS WITH CANCER AND FAMILY MEMBERS/CAREGIVERS M. Puts1,*, S. Sattar1, T. Fossat1, M. Fitch1, T. Hsu2, E. Szumacher3, D. Stephens4, G. Macdonald1, D. Macdonald4, B. Liu5,6, L. Jeffs7,8, J. Jones9,10, K. McGilton8,11, S. Alibhai12,13 1Lawrence S.Bloomberg Faculty of Nursing, University of Toronto, Toronto, 2Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, 3Radiation Oncology, Sunnybrook Health Sciences Centre, 4not applicable, not applicable, 5Division of Geriatric Medicine, Sunnybrook Health Sciences Centre, 6Division of Geriatric Medicine, University of Toronto, 7Nursing Research, St. Michael’s hospital, 8Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, 9ELLICSR, University Health Network, 10Psychiatry, University of Toronto, 11Toronto Rehabilitation Institute, 12Medicine, University Health Network, 13Medicine, University of Toronto, Toronto, Canada

134

P116 CHEMOTHERAPY TREATMENT DECISION-MAKING EXPERIENCES OF OLDER ADULTS WITH CANCER, THEIR FAMILY MEMBERS, CANCER SPECIALISTS AND FAMILY PHYSICIANS: A MIXED METHODS STUDY M. Puts1,*, S. Sattar1, K. McWatters1, K. Lee1, M. Kulik1, M. E. Macdonald1, R. Jang2, E. Amir2, M. Krzyzanowska2, N. Leighl2, M. Fitch1, A. Joshua2,3, P. Warde4, A. Tourangeau1, S. Alibhai5,6 1Nursing, University of Toronto, 2Medical Oncology, University Health Network, Toronto, Canada, 3Medical Oncology, Kinghorn Cancer Centre, Sydney, Australia, 4Radiation Oncology, 5Medicine, University Health Network, 6Medicine, University of Toronto, Toronto, Canada

135

P117 DEVELOPING A NATIONAL AGENDA ON CANCER AND AGING: THE CANADIAN NETWORK ON AGING AND CANCER (CNAC) M. Puts1,*, T. Hsu2, E. Szumacher3, S. Sattar1, S. Toubasi1, C. Rosario4, C. Mariano5, E. Brain6, S. Mohile7, H. Muss8, W. Duggleby9, D. Wan-Chow-Wah10, C. Wong11, M. Trudeau12, S. Alibhai4,13 1Nursing, University of Toronto, Toronto, 2Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, 3Radiation Oncology, Sunnybrook Health Sciences Centre, 4Medicine, University of Toronto, Toronto, 5Medical Oncology, Royal Columbian Hospital, Vancouver, Canada, 6Medical Oncology, Institut Curie, Paris, France, 7Medical Oncology, University of Rochester Medical Center, Rochester, 8Medical Oncology, School of Medicine UNC-Chapel Hill, Chapel Hill, USA, 9Nursing, Uiversity of Alberta, Edmonton, 10Division of Geriatric Medicine, McGill University Health Centre, Montreal, 11Geriatric Medicine, St. Michael’s Hospital, 12Medical Oncology, Sunnybrook Health Sciences Centre, 13Medicine, University Health Network, Toronto, Canada

135

P118 EVALUATION OF DIAGNOSTIC PATHWAYS FOR OLDER PEOPLE WITH SUSPECTED CANCER: AN ANALYSIS OF A RAPID ACCESS GERIATRIC ASSESSMENT SERVICE M. Denholm1,*, F. Holt1, P. Corrie2, J. Hampton3 1Department of Oncology and Department of Medicine for the Elderly, 2Department of Oncology, 3Department of Medicine for the Elderly, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

136

P119 IMPACT OF GERIATRIC ASSESSMENT ON THE MANAGEMENT OF OLDER ADULTS WITH HEAD AND NECK CANCER: A PILOT STUDY M. Neve1,* 1Radiation Oncology, Waikato Hospital, Hamilton, New Zealand

136

P120 ALTERATION OF DOMAINS IN COMPREHENSIVE GERIATRIC ASSESSMENTS AND SURVIVAL IN A FRENCH MULTICENTER COHORT OF ELDERLY PATIENTS WITH CANCER M. Frasca1,2,*, P. Soubeyran3,4,5,6, C. Bellera1,7, M. Rainfray1,2, S. Mathoulin-Pelissier1,4,7 and French ONCODAGE group 1Inserm U1219 Research Center, Epicene Team (Epidemiology of Cancer and Environmental Exposure), 2CHU Bordeaux, 3INSERM U1218 Research Unit, 4Bordeaux University, 5French National Cancer Institute (INCa) Integrated Cancer Research Site (SIRIC), Institut Bergonié, 6Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Center, 7Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France

137

P121 PREHABILITATION AND REHABILITATION IN ONCOGERIATRICS: ADAPTATION TO DISEASE AND ACCOMPANIMENT OF PATIENTS’ TRAJECTORIES O. Le Saux1,*, C. Falandry1 1Geriatric oncology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France

138

P122 EDUCATING 400 NURSES IN GERIATRIC ONCOLOGY ACROSS THE US (FUNDED BY THE NATIONAL INSTITUTE OF HEALTH #R25CA183723-01A1) P. S. Burhenn1,*, C. Okamoto2, D. Economou3, R. Yang1, C. Sun4, A. Hurria5 1Geriatric Oncology, 2Professional Practice and Education, 3Nursing Research and Education, 4Outcomes Research, 5Cancer and Aging Research Program, City of Hope National Medical Center, Duarte, USA

138

P123 FACTORS INFLUENCING TREATMENT DECISIONS MADE BY OLDER WOMEN WITH PRIMARY BREAST CANCER P. Howard1,*, K. L. Cheung2, K. Cox1 1School of Health Science, 2School of Medicine, University of Nottingham, Nottingham, United Kingdom

139

P124 CHEMOTHERAPY PRESCRIBING FOR OLDER ADULTS WITH CANCER: A SURVEY OF AUSTRALIAN ONCOLOGISTS E. Moth1, B. E. Kiely1, V. Naganathan2, A. Martin3, P. Blinman1,* 1Concord Cancer Centre, 2Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, 3NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia

139

P125 ESTIMATING THE RISK OF SEVERE CHEMOTHERAPY TOXICITY IN ADULTS 65 YEARS: COMPARING THE CARG SCORE WITH ONCOLOGISTS’ ESTIMATES OF TOXICITY E. Moth1, B. E. Kiely1, P. Beale1, M. R. Stockler1, P. Grimison2, N. Stefanic3, A. Martin2, V. Naganathan4, P. Blinman1,* 1Concord Cancer Centre, Concord Repatriation General Hospital, Concord, 2Medical Oncology, The Chris O’Brien Lifehouse, 3University of Sydney, Sydney, 4Centre for Education and Research on Ageing, Concord Repatriation General Hospital, Concord, Australia

140

P126 IMPACT OF A WEEKLY MULTIDISCIPLINARY GERIATRIC ONCOLOGY MEETING ON THERAPEUTIC MANAGEMENT OF OLDER PATIENTS WITH CANCER R. Moor1,*, P. Cornette2, V. Verschaeve3, G. Debugne4, Y. Humblet5, I. Gilard2, I. Clement Corral6, P. Betomvuko6, R. Poletto7, N. Nols8, F. Blancke9, F. Cornélis5 1Geriatric Oncology, 2Geriatrics, Cliniques Universitaires Saint-Luc, Bruxelles, 3Medical Oncology, Grand Hôpital de Charleroi, Charleroi, 4Geriatrics, Centre Hospitalier de Mouscron, Mouscron, 5Medical Oncology, Cliniques Universitaires Saint-Luc, Bruxelles, 6Geriatrics, 7Geriatric Oncology, Grand Hôpital de Charleroi, Charleroi, 8Hematology, 9Geriatric Oncology, Centre Hospitalier de Mouscron, Mouscron, Belgium

141

P127 DOES THE VULNERABLE ELDERS SURVEY (VES-13) CORRELATE WITH THE PRESENCE OF GERIATRIC ISSUES AND SYNDROMES IN OLDER ADULTS WITH GENITOURINARY CANCER? R. Jin1,*, A. Loucks1, M. Puts2, P. Savage1, T. Stuart-McEwan1, S. Alibhai1 1Princess Margaret Cancer Centre, 2University of Toronto, Toronto, Canada

141

P128 FEASIBILITY OF INTRODUCING VULNERABILITY SCREENING IN AN AMBULATORY CANCER CLINIC R. Jin1,*, A. Loucks1, M. Puts2, P. Savage1, T. Stuart-McEwan1, S. Alibhai1 1Princess Margaret Cancer Centre, 2University of Toronto, Toronto, Canada

142

P129 THE EFFECT OF COMPREHENSIVE GERIATRIC ASSESSMENT ON TREATMENT DECISIONS AND MORTALITY AMONGST OLDER PATIENTS TREATED FOR UPPER GASTROINTESTINAL CANCER R. Morris1,*, J. Pattinson1, A. Sims1, J. Brown1, A. Cowley1, T. Masud1 1Health Care for Older People, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

143

P130 MULTIMORBIDITY AND HEALTH OUTCOMES IN OLDER ADULTS: A FOCUS ON CANCER SURVIVORS D. F. Warner1, N. K. Schiltz2, K. C. Stange3, C. W. Given4, C. Owusu5, N. A. Berger5, S. M. Koroukian2,* 1Sociology, University of Nebraska, Lincoln, 2Epidemiology and Biostatistics, 3Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, 4Department of Family Medicine, Michigan State University, East Lansing, 5Hematology/Oncology, University Hospitals of Cleveland, Cleveland, USA

143

P131 TRAJECTORIES OF FUNCTIONAL LIMITATIONS AND HEALTH STATUS BY CANCER SURVIVOR STATUS: DOES THE GAP CLOSE WITH LONGER SURVIVORSHIP? D. F. Warner1, N. K. Scihltz2, K. C. Stange3, C. Given4, C. Owusu5, N. A. Berger6, S. M. Koroukian2,* 1Sociology, University of Nebraska, Lincoln, 2Epidemiology and Biostatistics, 3Family Medicine and Community Health, Case Western Reserve University, Cleveland, 4Family Medicine, Michigan State University, East Lansing, 5Hematology/ Oncology, 6Hematology/Oncology, University Hospitals of Cleveland/Case Medical Center, Cleveland, USA

144

P132 BARRIERS TO GOOD MEDICATION TAKING BEHAVIOUR IN METASTATIC PROSTATE CANCER PATIENTS RECEIVING ORAL ANTI-ANDROGEN THERAPY S. Ahrari1,2,*, K. Farr1, L. Buddo1,3, A. Thawer1, A. Giotis1, M. Puts4, C. De Angelis1,2 1Pharmacy, Sunnybrook Odette Cancer Centre, 2Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, 3Pharmacy, University of Waterloo, Waterloo, 4Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada

145

P133 THE DEVELOPMENT OF DISTRESS IN OLDER PATIENTS WITH CANCER IN THE MID-LONG TERM S. Dauphin1,*, T. De Burghgraeve1, F. Buntinx1,2, M. van den Akker1,2 1Department of General Practice, KU Leuven, Leuven, Belgium, 2Department of Family Medicine, Maastricht University, Maastricht, Netherlands

145

P134 THE UK GERIATRIC ONCOLOGY EXPERT REFERENCE GROUP (ERG) CONSENSUS ON CGA SCREENING T. Kalsi1,2,*, D. Harari1,2 and The UK Geriatric Oncology Expert Reference Group 1Department of Ageing & Health, Guys & St Thomas’ NHS Foundation Trust, 2Division of Health and Social Care Research, Kings College London, London, United Kingdom

146

P135 UK ASSESSMENT METHODS AND SERVICES FOR OLDER PEOPLE WITH CANCER: A NATIONAL SURVEY T. Kalsi1,2,*, D. Harari1,2 1Department of Ageing & Health, Guys & St Thomas’ NHS Foundation Trust, 2Division of Health and Social Care Research, Kings College London, London, United Kingdom

146

P136 ONCOLOGICAL SURGERY IN AGED 80 OR MORE: PREDICTORS OF FUNCTIONAL DECLINE AND MORTALITY IN ONE YEAR L. A. Gil-Jr1, T. Karnakis1,*, A. L. Kanaji1, B. A. Martins1, J. C. Oliveira2, M. D. C. Sitta3, W. Jacob-Filho3 1Geriatrics, 2Internal Medicine, Cancer Institute of Sao Paulo, 3Geriatrics, University of Sao Paulo, Sao Paulo, Brazil

147

P137 THE LONGITUDINAL USE OF GERIATRIC ASSESSMENT IN AN ONCOLOGY CENTER IN BRAZIL: A PILOT STUDY IN PATIENTS WITH BREAST CANCER T. Karnakis1,*, R. Kaliks2, A. Del Giglio3, W. Jacob Filho4 1Geriatrics, ICESP, 2Oncology, 3Albert Eisntein Hospital, 4Geriatrics, University of São Paulo, São Paulo, Brazil

148

P138 ASSESSMENT OF OLDER PATIENTS WITH CANCER: EDMONTON FRAIL SCALE (EFS) AS A PREDICTOR OF ADVERSE OUTCOMES IN OLDER PATIENTS UNDERGOING RADIOTHERAPY T. Ryan1, L. Keenan1,*, M. O’Brien2, O. McCardle1 1Radiation Oncology, SLRON, 2Geriatrics, Beaumont Hospital, Dublin, Ireland

148

P139 TRAINING MEDICAL ONCOLOGISTS TO ADDRESS THE NEEDS OF AGING CANCER PATIENTS T. Hsu1,*, W. Dale2, A. Gajra3, H. M. Holmes4, E. R. Kessler5, R. Maggiore6, A. Magnuson7, I. Parker8, A. Hurria9 1The Ottawa Hospital Cancer Centre, Ottawa, Canada, 2University of Chicago Medical Center, Chicago, 3Upstate Cancer Center, Syracuse, 4University of Texas Health Science Center at Houston, Houston, 5University of Colorado School of Medicine, Aurora, 6Oregon Health and Science University, Portland, 7University of Rochester Medical Center, Rochester, 8ElderCare Mediation Solutions, La Jolla, 9City of Hope National Comprehensive Cancer Center, Duarte, USA

149

P140 GERIATRIC RESEARCH POLICY OF THE JAPAN CLINICAL ONCOLOGY GROUP T. Mizutani1,*, K. Nakamura1, A. Ogawa2, T. Hmaguchi1, H. Fukuda1, F. Nagashima3 1National Cancer Center, Tokyo, 2National Cancer Center Hospital East, Chiba, 3Kyorin University School of Medicine, Tokyo, Japan

150

P141 COUPLES COPING WITH CANCER IN THE PLATINUM STAGE OF LIFE: OLDEST-OLD AND THEIR SPOUSAL CAREGIVERS G. Goldzweig1, E. Andritsch2, R. Pfeffer3, L. Baider3, Y. Rottenberg4,* 1School of Behavioral Sciences, Tel-Aviv-Yaffo Academic College, Tel-aviv, Israel, 2Division of Clinical Oncology, The medical University of Graz, Graz, Austria, 3Assuta Medical Center, Oncology Institute, Tel-aviv, 4Hadassah - Hebrew University Medical Center, Jerusalem, Israel

150

P142 THE ROLE OF THE SOCIAL WORKER IN A COMPREHENSIVE GERIATRIC ASSESSMENT CLINIC FOR OLDER PEOPLE WITH UPPER GASTROINTESTINAL CANCER R. Morris1, Y. Raza2,*, P. McKay3, H. Jones4 1Health Care for Older People, Nottingham University Hospitals NHS Trust, 2Adult Access Service, 3South Nottinghamshire and Public Protection, Nottinghamshire County Council, 4Adult Social Services, Nottingham City Council, Nottingham, United Kingdom

151

P143 FUNCTIONAL STATUS, QUALITY OF LIFE, AND UNMET NEEDS IN OLDER PATIENTS WITH LUNG CANCER K. K.-F. Cheng1,*, S. Y. Loh2, C. K. Toh2, Z. Huang1 1National University of Singapore, 2National Cancer Centre Singapore, Singapore, Singapore

151

P144 DIALOG TASK FORCE FOR DEFINITION OF A GERIATRIC MINIMUM DATA SET FOR CLINICAL ONCOLOGY RESEARCH E. Paillaud1,2,*, P. Caillet3, T. Cudennec4, F. Pamoukdjian5, V. Fossey-Diaz6, E. Liuu7, G. Albrand8, R. Boulahssess9, A. L. Couderc10, C. Mertens11, F. Retornaz12, L. Balardy13, F. Rollot-Trad14, L. De Decker15, T. Aparicio16, C. Terret17, H. Le Caer18, E. Carola19, H. Cure20, S. Culine21, L. Mourey22, E. Brain23, P. Soubeyran24 and DIALOG

152